Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4300905 | 1.00 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| Water SCHEMBL429998 | 0.98 | APP (0.42) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL395722 | 0.97 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL29462018 | 0.95 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| Hydrochloric Acid SCHEMBL5070335 | 0.95 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL2187038 | 0.88 | APP (0.42) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL1492489 | 0.84 | PTGS1 (0.39) | APPPTGS1PDE4ALMNASLC6A6 | |
| Butylamine SCHEMBL6244958 | 0.82 | APP (0.54) | APPLMNASLC6A6CYP2C19BLM | |
| SCHEMBL6244160 | 0.82 | EPHX2 (0.37) | APPEPHX2 | |
| SCHEMBL1825217 | 0.81 | PTGS1 (0.41) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 963 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117347415-A | Method for identifying disulfide bonds of polypeptide drugs based on high-field nuclear magnetic resonance technology | 江苏国源先进仪器技术研究院有限公司 | 2024-01-05 | — | — | CN | claimed |
| WO-2021072139-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-04-15 | — | — | WO | claimed |
| US-20210106525-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2021-04-15 | — | — | US | claimed |
| CN-110806421-B | NMR detection method for PAMAM and guest small molecule interaction mode | 中国科学院山西煤炭化学研究所 | 2021-02-09 | — | — | CN | claimed |
| CN-109696451-B | NMR determination method of PAMAM (polyamidoamine) on guest small molecule adsorption quantity | 中国科学院山西煤炭化学研究所 | 2020-08-28 | — | — | CN | claimed |
| CN-108425101-B | Coating treatment process for precious metal product | 浙江银之源贵金属有限公司 | 2020-05-19 | — | — | CN | claimed |
| CN-110806421-A | NMR detection method for PAMAM and guest small molecule interaction mode | 中国科学院山西煤炭化学研究所 | 2020-02-18 | — | — | CN | claimed |
| CN-108872289-A | Manuka honey discrimination method based on nuclear magnetic resonance technique | 江苏出入境检验检疫局动植物与食品检测中心 | 2018-11-23 | — | — | CN | claimed |
| CN-108614000-A | Manuka honey discrimination method based on SIMCA models | 江苏出入境检验检疫局动植物与食品检测中心 | 2018-10-02 | — | — | CN | claimed |
| EP-1556437-B1 | ANTISTATIC AGENTS AND POLYMER COMPOSITIONS DERIVED THEREFROM | GEN ELECTRIC (US) | 2008-07-30 | — | — | EP | claimed |
| EP-1556437-A1 | ANTISTATIC AGENTS AND POLYMER COMPOSITIONS DERIVED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2005-07-27 | — | — | EP | claimed |
| US-6900257-B2 | Antistatic agents and polymer compositions derived therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-05-31 | — | — | US | claimed |
| WO-2004013218-A1 | ANTISTATIC AGENTS AND POLYMER COMPOSITIONS DERIVED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2004-02-12 | — | — | WO | claimed |
| US-20040030015-A1 | Antistatic agents and polymer compositions derived therefrom | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2004-02-12 | — | — | US | claimed |
| EP-0347588-B1 | Heparin derivatives and process for their preparation | ALFA WASSERMANN SPA (IT) | 1994-07-27 | — | — | EP | claimed |
| EP-0132349-B1 | ANTIBIOTIC CALLED \"CHLOROPOLYSPORIN\", A PROCESS FOR ITS PREPARATION, AND ITS THERAPEUTIC AND VETERINARY USE | SANKYO COMPANY LIMITED (JP) | 1990-10-10 | — | — | EP | claimed |
| US-4557933-A | Antibiotic called \"chloropolysporin\", a process for its preparation, and its therapeutic and veterinary use | SANKYO COMPANY LIMITED (JP) | 1985-12-10 | — | — | US | claimed |
| EP-0132349-A2 | Antibiotic called \"chloropolysporin\", a process for its preparation, and its therapeutic and veterinary use | SANKYO COMPANY LIMITED (JP) | 1985-01-30 | — | — | EP | claimed |
| US-4201769-A | ENZYME INHIBITORS, SYNERGISTIC | SANKYO COMPANY LIMITED (JP) | 1980-05-06 | — | — | US | claimed |
| US-20260099107-A1 | TONER | CANON KK (JP) | 2026-04-09 | — | — | US | disclosed |
| US-20260091054-A1 | Gel-Forming Material and Gel Composition | KEWPIE CORPORATION (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20260076901-A1 | Material for Gel Formation and Gel Composition | KEWPIE CORPORATION (JP) | 2026-03-19 | — | — | US | disclosed |
| US-12577599-B2 | Synthesis of human milk oligosaccharides by a beta-N-acetylhexosaminidase from Haloferula sp | CHINA AGRICULTURAL UNIVERSITY (CN) | 2026-03-17 | — | — | US | disclosed |
| US-20250239613-A1 | BINDER MATERIAL AND METHODS THEREOF | DAICEL CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| EP-4570267-A1 | MATERIAL FOR GEL FORMATION AND GEL COMPOSITION | Kewpie Corporation (JP) | 2025-06-18 | — | — | EP | disclosed |
| EP-4570268-A1 | GEL-FORMING MATERIAL AND GEL COMPOSITION | Kewpie Corporation (JP) | 2025-06-18 | — | — | EP | disclosed |
| US-20250154455-A1 | BIOACTIVE AND ANTIOXIDANT SUPRAMOLECULAR POLYMER HYDROGELS FOR NEURAL CELL CULTURE | NORTHWESTERN UNIVERSITY | 2025-05-15 | — | — | US | disclosed |
| US-20250144614-A1 | ANION EXCHANGE RESIN, ANION EXCHANGE MEMBRANE, ANION-EXCHANGE-GROUP-CONTAINING MONOMER, AND QUATERNARY-IMIDAZOLE-GROUP-CONTAINING MONOMER | KAKE EDUCATIONAL INSTITUTION (JP) | 2025-05-08 | — | — | US | disclosed |
| CN-119488910-A | Preparation of d-orbit metal surface plasmon heterostructure photocatalyst and application thereof in low-hydrocarbon activation conversion into acetic acid | 中国科学技术大学 | 2025-02-21 | — | — | CN | disclosed |
| US-20240277855-A1 | POLYOXYETHYLENE DERIVATIVES AND CONJUGATES THEREOF | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2024-08-22 | — | — | US | disclosed |
| US-20240279466-A1 | AN AMINOSQUARAMIDE POLYMER | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2024-08-22 | — | — | US | disclosed |
| US-20240264544-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2024-08-08 | — | — | US | disclosed |
| EP-3216520-B1 | MOLDING CONTAINING A ZEOLITIC MWW TYPE MATERIAL CONTAINING TI AND ZN AND USE THEREOF AS A CATALYST | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| CN-118221846-A | Ginseng hemicellulose for inhibiting obesity and preparation method and application thereof | 长春中医药大学 | 2024-06-21 | — | — | CN | disclosed |
| WO-2024123968-A1 | RNA TARGETING COMPOUNDS AND USES THEREOF | RANAR THERAPEUTICS, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| US-11993627-B2 | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-05-28 | — | — | US | disclosed |
| US-20240167070-A1 | METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Ny-HYDROXY- OR Ny-AMINO-L-ASPARAGINE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-05-23 | — | — | US | disclosed |
| EP-4370587-A1 | AN AMINOSQUARAMIDE POLYMER | Universitat de les Illes Balears (ES) | 2024-05-22 | — | — | EP | disclosed |
| US-20240158564-A1 | QUATERNARY AMMONIUM-FUNCTIONALIZED POLYMERS AND METHODS OF MAKING AND USING SAME | U.S. DEPARTMENT OF ENERGY | 2024-05-16 | — | — | US | disclosed |
| US-20240158925-A1 | A MEMBRANE-FREE ALKALINE ELECTROLYZER FOR UPCYCLING WASTE INTO AMMONIA | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2024-05-16 | — | — | US | disclosed |
| US-11981712-B2 | Polypeptides capable of producing glucans having alpha (1-->2) linkages and use of the same | Nutrition & Biosciences USA 4, Inc. (US) | 2024-05-14 | — | — | US | disclosed |
| US-11975113-B2 | Wound dressing containing crosslinked gelatin derivative particles | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2024-05-07 | — | — | US | disclosed |
| CN-117986396-A | Preparation method of water-soluble Antarctic arbuscular algae uniform polysaccharide, product and application thereof | 云南贝泰妮生物科技集团股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-112166095-B | Process for the preparation of aromatic compounds from biomass | 巴斯夫欧洲公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20240108642-A1 | GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF | DSM NUTRITIONAL PRODUCTS, LLC | 2024-04-04 | — | — | US | disclosed |
| CN-110446511-B | Short acting heparin-based anticoagulant compounds and methods | 北卡罗来纳大学查珀尔希尔分校 | 2024-04-02 | — | — | CN | disclosed |
| US-11946023-B2 | Glucan fiber compositions for use in laundry care and fabric care | Nutrition & Biosciences USA 4, Inc. (US) | 2024-04-02 | — | — | US | disclosed |
| WO-2024062713-A1 | GEL-FORMING MATERIAL AND GEL COMPOSITION | キユーピー株式会社 | 2024-03-28 | — | — | WO | disclosed |
| CN-117733166-A | Monoatomic copper catalyst and preparation method and application thereof | 国电电力发展股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| WO-2024053159-A1 | MATERIAL FOR GEL FORMATION AND GEL COMPOSITION | キユーピー株式会社 | 2024-03-14 | — | — | WO | disclosed |
| US-20240084394-A1 | URINARY METABOLOMIC BIOMARKERS FOR DETECTING COLORECTAL CANCER AND POLYPS | METABOLOMIC TECHNOLOGIES INC. (CA) | 2024-03-14 | — | — | US | disclosed |
| US-20240075059-A1 | METHODS OF SELECTIVELY PROMOTING GASTROINTESTINAL MICROBIAL GROWTH | DSM IP ASSETS B.V. (NL) | 2024-03-07 | — | — | US | disclosed |
| US-20240066048-A1 | SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-02-29 | — | — | US | disclosed |
| EP-3858850-B1 | NONAPEPTIDE PREVENTING INCREASED HYPERPERMEABILITY OF VASCULAR ENDOTHELIUM | FEDERALNOYE GOSUDARSTVENNOE BUDGETNOE UCHREZHDENIE NAC MEDICINSKIY ISSLEDOVATELSKIY CENTR KARDIOLOGI (RU) | 2024-02-28 | — | — | EP | disclosed |
| US-11903963-B2 | Short-acting heparin-based anticoagulant compounds and methods | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-02-20 | — | — | US | disclosed |
| US-11898061-B2 | Modified conductive structure and method for producing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2024-02-13 | — | — | US | disclosed |
| CN-117535717-A | Nitrogen-doped aerogel copper-based catalyst and preparation method and application thereof | 国能锦界能源有限责任公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11883422-B2 | Glycan therapeutic compositions and related methods thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2024-01-30 | — | — | US | disclosed |
| US-11884942-B2 | Compositions and methods comprising the use of Exiguobacterium acetylicum and Bacillus coagluans α-glucanotransferase enzymes | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2024-01-30 | — | — | US | disclosed |
| US-20240027929-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2024-01-25 | — | — | US | disclosed |
| CN-117385404-A | Electrode loaded with in-situ reconstruction copper-carbon composite catalyst and preparation method and application thereof | 国家能源集团新能源技术研究院有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117347543-A | Quasi-targeting metabonomics method based on cholic amine derivatization and application thereof | 北京农学院 | 2024-01-05 | — | — | CN | disclosed |
| US-11859022-B2 | Alpha-1,3-glucan graft copolymers | Nutrition & Biosciences USA 4, Inc. (US) | 2024-01-02 | — | — | US | disclosed |
| EP-4295840-A2 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | DSM Nutritional Products, LLC (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20230405091-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP ASSETS B.V. (NL) | 2023-12-21 | — | — | US | disclosed |
| US-20230408945-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-12-21 | — | — | US | disclosed |
| US-20230408942-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-12-21 | — | — | US | disclosed |
| US-20230408946-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-12-21 | — | — | US | disclosed |
| CN-117210851-A | Electrode loaded with copper nano-beam catalyst and preparation method and application thereof | 国能锦界能源有限责任公司 | 2023-12-12 | — | — | CN | disclosed |
| US-11840720-B2 | Urinary metabolomic biomarkers for detecting colorectal cancer and polyps | METABOLOMIC TECHNOLOGIES INC. (CA) | 2023-12-12 | — | — | US | disclosed |
| EP-4280891-A1 | METHODS OF SELECTIVELY PROMOTING GASTROINTESTINAL MICROBIAL GROWTH | DSM IP Assets B.V. (NL) | 2023-11-29 | — | — | EP | disclosed |
| EP-3024581-B1 | REGENERATION OF A TITANIUM CONTAINING ZEOLITE | BASF SE (DE) | 2023-11-15 | — | — | EP | disclosed |
| US-20230350319-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230346943-A1 | SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-11-02 | — | — | US | disclosed |
| EP-4270109-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4270110-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-11-01 | — | — | EP | disclosed |
| CN-116974161-A | Toner and method for producing the same | 佳能株式会社 | 2023-10-31 | — | — | CN | disclosed |
| CN-116974163-A | Toner and method for producing the same | 佳能株式会社 | 2023-10-31 | — | — | CN | disclosed |
| CN-116940690-A | Comprising N γ -hydroxy-or N γ Polypeptide cyclization method of amino-L-asparagine | 南洋理工大学 | 2023-10-24 | — | — | CN | disclosed |
| EP-3551194-B1 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2023-10-18 | — | — | EP | disclosed |
| WO-2023195932-A2 | USES OF DIAZIRINES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2023-10-12 | — | — | WO | disclosed |
| EP-3870616-B1 | ALPHA-1,3-GLUCAN GRAFT COPOLYMERS | DUPONT IND BIOSCIENCES USA LLC (US) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023190590-A1 | ANION EXCHANGE RESIN, ANION EXCHANGE MEMBRANE, ANION-EXCHANGE-GROUP-CONTAINING MONOMER, AND QUATERNARY-IMIDAZOLE-GROUP-CONTAINING MONOMER | 学校法人加計学園 | 2023-10-05 | — | — | WO | disclosed |
| CN-116773581-A | High-resolution nuclear magnetic resonance in-situ measurement device and method for carbon dioxide electroreduction reaction | 厦门大学 | 2023-09-19 | — | — | CN | disclosed |
| EP-3490705-B1 | CATALYSTS FOR MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | PROCTER & GAMBLE (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4228424-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP Assets B.V. (NL) | 2023-08-23 | — | — | EP | disclosed |
| CN-109476620-B | Method for purifying propylene oxide | 巴斯夫欧洲公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-116622006-A | Short acting heparin-based anticoagulant compounds and methods | 北卡罗来纳大学查珀尔希尔分校 | 2023-08-22 | — | — | CN | disclosed |
| US-20230255989-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2023-08-17 | — | — | US | disclosed |
| WO-2023137449-A2 | METHODS OF ASSESSING CARCASS MUSCLE BIOMARKERS TO DISCRIMINATE CHARACTERISTICS OF THE MEAT | PURDUE RESEARCH FOUNDATION (US) | 2023-07-20 | — | — | WO | disclosed |
| WO-2023131849-A1 | MIXTURE OF STEREOISOMERS OF A SULFATED GLYCOLIPID | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2023-07-13 | — | — | WO | disclosed |
| CN-110770217-B | Propylene recovery by washing with solvent/water mixtures | 巴斯夫欧洲公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-116406301-A | SN38 peptide conjugates useful in the treatment of cancer | 生物医药研究基金会机构(IRB巴塞罗那) | 2023-07-07 | — | — | CN | disclosed |
| CN-116390651-A | Methods of modulating gastrointestinal metabolites | 帝斯曼知识产权资产管理有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-11691932-B2 | Process for the preparation of an aromatic compound from biomass | BASF SE (DE) | 2023-07-04 | — | — | US | disclosed |
| US-20230200412-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP ASSETS B.V. (NL) | 2023-06-29 | — | — | US | disclosed |
| US-20230201829-A1 | ASSEMBLIES AND METHODS | UNVERSITEIT LEIDEN (NL) | 2023-06-29 | — | — | US | disclosed |
| CN-116332724-A | Method for preparing methanol by partial oxidation of coal bed gas | 中国科学技术大学 | 2023-06-27 | — | — | CN | disclosed |
| CN-116270718-A | Glycan therapeutic and methods of treatment | DSM营养产品有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-109641861-B | Method for producing propylene oxide | 巴斯夫欧洲公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-109476619-B | Method for purifying propylene oxide | 巴斯夫欧洲公司 | 2023-05-12 | — | — | CN | disclosed |
| US-20230132667-A1 | DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF VIRAL RNA STRUCTURES | UNIVERSITY OF WASHINGTON (US) | 2023-05-04 | — | — | US | disclosed |
| EP-4157847-A1 | DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF VIRAL RNA STRUCTURES | University of Washington (US) | 2023-04-05 | — | — | EP | disclosed |
| US-20230099785-A1 | ROBUST PALLADIUM HYDRIDE CATALYST FOR ELECTROCATALYTIC FORMATE FORMATION WITH HIGH CO TOLERANCE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-30 | — | — | US | disclosed |
| US-20230096592-A1 | DETERMINATION OF MODIFICATION DEGREE OF THERAPEUTIC PROTEINS USING 1H-NMR SPECTROSCOPY | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-03-30 | — | — | US | disclosed |
| CN-113574074-B | Alpha-1,3-glucan graft copolymer | 营养与生物科学美国第四公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2023285627-A1 | AN AMINOSQUARAMIDE POLYMER | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2023-01-19 | — | — | WO | disclosed |
| EP-4118090-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP Assets B.V. (NL) | 2023-01-18 | — | — | EP | disclosed |
| US-20230011163-A1 | Synthesis of human milk oligosaccharides by a Beta-N-acetylhexosaminidase from Haloferula sp. | CHINA AGRICULTURAL UNIVERSITY (CN) | 2023-01-12 | — | — | US | disclosed |
| EP-4111185-A1 | DETERMINATION OF MODIFICATION DEGREE OF THERAPEUTIC PROTEINS USINGH-NMR SPECTROSCOPY | Takeda Pharmaceutical Company Limited (JP) | 2023-01-04 | — | — | EP | disclosed |
| CN-115551873-A | Methods for modulating gastrointestinal microbial metabolic pathways and metabolites | 帝斯曼知识产权资产管理有限公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-4108691-A1 | IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | Cornell University (US) | 2022-12-28 | — | — | EP | disclosed |
| CN-109071475-B | Method for preparing propylene oxide | 巴斯夫欧洲公司 | 2022-12-27 | — | — | CN | disclosed |
| US-20220395521-A1 | MICROBIOME REGULATORS AND RELATED USES THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2022-12-15 | — | — | US | disclosed |
| CN-115282340-A | GelMA-based biological ink and preparation method and application thereof | 深圳大洲医学科技有限公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-115197432-A | Antibacterial/antiviral high polymer material and preparation method thereof | 中国科学院长春应用化学研究所 | 2022-10-18 | — | — | CN | disclosed |
| CN-107427528-B | Glycan therapeutics and methods related thereto | 卡莱多生物科技有限公司 | 2022-09-23 | — | — | CN | disclosed |
| WO-2022186782-A1 | METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Nγ-HYDROXY- OR Nγ-AMINO-L-ASPARAGINE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-09-09 | — | — | WO | disclosed |
| US-20220282183-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2022-09-08 | — | — | US | disclosed |
| US-11414628-B2 | Glucan fiber compositions for use in laundry care and fabric care | Nutrition & Biosciences USA 4, Inc. (US) | 2022-08-16 | — | — | US | disclosed |
| US-11415902-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2022-08-16 | — | — | US | disclosed |
| EP-3565017-B1 | ELECTROCHEMICAL LIGHT EMITTING CELL | JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECH (JP) | 2022-07-20 | — | — | EP | disclosed |
| CN-110947427-B | Metal-ligand co-catalysis by nitrogen-hydrogen arm deprotonation/pyridine dearomatization for efficient hydrogen generation from formic acid | 阿卜杜拉国王科技大学 | 2022-07-19 | — | — | CN | disclosed |
| US-11385230-B2 | Methods for the assessment of colorectal cancer and colorectal polyps by measurement of metabolites in urine | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-07-12 | — | — | US | disclosed |
| CN-108289494-B | Polypeptides capable of producing glucans with alpha-1, 2 branching and uses thereof | 营养与生物科学美国4公司 | 2022-06-14 | — | — | CN | disclosed |
| US-11352589-B2 | Glucan fiber compositions for use in laundry care and fabric care | Nutrition & Biosciences USA 4, Inc. (US) | 2022-06-07 | — | — | US | disclosed |
| CN-111065421-B | Wound dressing containing particles of cross-linked gelatin derivative | 国立研究开发法人物质·材料研究机构 | 2022-04-29 | — | — | CN | disclosed |
| US-20220127413-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2022-04-28 | — | — | US | disclosed |
| US-20220125074-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP ASSETS B.V. (NL) | 2022-04-28 | — | — | US | disclosed |
| CN-114384773-A | Toner and method for producing toner | 佳能株式会社 | 2022-04-22 | — | — | CN | disclosed |
| WO-2022079238-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP ASSETS B.V. (NL) | 2022-04-21 | — | — | WO | disclosed |
| CN-111534503-B | Application of Haloferrila sp | 中国农业大学 | 2022-04-08 | — | — | CN | disclosed |
| CN-111556709-B | Methods for improving seed germination and/or plant tolerance to environmental stress | 丹斯塔发酵股份公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-109415290-B | Method for producing acrylic acid from lactic acid or derivatives thereof in liquid phase | 宝洁公司 | 2022-03-08 | — | — | CN | disclosed |
| US-11261264-B2 | Enzymatic synthesis of soluble glucan fiber | Nutrition & Biosciences USA 4, Inc. (US) | 2022-03-01 | — | — | US | disclosed |
| US-11242432-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | CORNELL UNIVERSITY (US) | 2022-02-08 | — | — | US | disclosed |
| CN-108368492-B | Compositions and methods comprising use of a bacillus acetobacter and bacillus coagulans alpha-glucanotransferase | 杜邦营养生物科学有限公司 | 2022-01-28 | — | — | CN | disclosed |
| US-11229660-B2 | Glycan therapeutics and method of treating conditions associated with TMAO | KALEIDO BIOSCIENCES, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| US-20210401861-A1 | GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2021-12-30 | — | — | US | disclosed |
| WO-2021242770-A1 | DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF VIRAL RNA STRUCTURES | UNIVERSITY OF WASHINGTON (US) | 2021-12-02 | — | — | WO | disclosed |
| US-11180467-B2 | Propene recovery by scrubbing with a solvent/water mixture | BASF SE (DE) | 2021-11-23 | — | — | US | disclosed |
| CN-113645850-A | Methods of modulating gastrointestinal metabolites | 帝斯曼知识产权资产管理有限公司 | 2021-11-12 | — | — | CN | disclosed |
| US-20210340178-A1 | NONAPEPTIDE PREVENTING INCREASED HYPERPERMEABILITY OF VASCULAR ENDOTHELIUM | FEDERALNOYE GOSUDARSTVENNOE BUDGETNOE UCHREZHDENIE "NACIONALNIY MEDICINSKIY ISSLEDOVATELSKIY CENTR KARDIOLOGII" MINISTERSTVA ZDRAVOOHRANENIYA ROSSIISKOY FEDERACII (RU) | 2021-11-04 | — | — | US | disclosed |
| CN-108026213-B | Imidazole and imidazolium cations with special base stability | 康奈尔大学 | 2021-11-02 | — | — | CN | disclosed |
| CN-113574074-A | Alpha-1, 3-glucan graft copolymers | 营养与生物科学美国第四公司 | 2021-10-29 | — | — | CN | disclosed |
| US-20210332076-A1 | ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2021-10-28 | — | — | US | disclosed |
| CN-110121795-B | Electrochemical light-emitting cell | 国立大学法人北陆先端科学技术大学院大学 | 2021-09-24 | — | — | CN | disclosed |
| WO-2021183896-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP ASSETS, B.V. (NL) | 2021-09-16 | — | — | WO | disclosed |
| EP-3876747-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP Assets B.V. (NL) | 2021-09-15 | — | — | EP | disclosed |
| US-20210253495-A1 | PROCESS FOR THE PREPARATION OF AN AROMATIC COMPOUND FROM BIOMASS | BASF SE (DE) | 2021-08-19 | — | — | US | disclosed |
| CN-110885809-B | alpha-L-fucosidase and related biological material and application thereof | 中国农业大学 | 2021-08-17 | — | — | CN | disclosed |
| CN-106410292-B | Alkaline storage battery | 株式会社杰士汤浅国际 | 2021-08-13 | — | — | CN | disclosed |
| EP-3862002-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| EP-3858850-A1 | NONAPEPTIDE PREVENTING INCREASED HYPERPERMEABILITY OF VASCULAR ENDOTHELIUM | Federalnoye Gosudarstvennoe Budgetnoe Uchrezhdenie "Nacionalniy Medicinskiy Centr Kardiologii" Minis- terstva Zdravoohraneniya Rossiiskoy Federacii (RU) | 2021-08-04 | — | — | EP | disclosed |
| WO-2021150621-A1 | SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | disclosed |
| US-11072783-B2 | Compositions and methods comprising the use of exiguobacterium acetylicum and bacillus coagluans alpha-glucanotransferase enzymes | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2021-07-27 | — | — | US | disclosed |
| WO-2021140789-A1 | METHOD FOR DECOMPOSING CHITIN AND METHOD FOR PRODUCING CHITIN OLIGOSACCHARIDE-CONTAINING COMPOSITION | 国立大学法人北海道大学 | 2021-07-15 | — | — | WO | disclosed |
| US-20210206819-A1 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2021-07-08 | — | — | US | disclosed |
| US-20210189499-A1 | URINARY METABOLOMIC BIOMARKERS FOR DETECTING COLORECTAL CANCER AND POLYPS | METABOLOMIC TECHNOLOGIES INC. (CA) | 2021-06-24 | — | — | US | disclosed |
| US-20210183469-A9 | COMPUTATIONAL PLATFORM FOR IN SILICO COMBINATORIAL SEQUENCE SPACE EXPLORATION AND ARTIFICIAL EVOLUTION OF PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-17 | — | — | US | disclosed |
| US-11034641-B2 | Methods of making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2021-06-15 | — | — | US | disclosed |
| US-20210171868-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2021-06-10 | — | — | US | disclosed |
| US-20210171867-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2021-06-10 | — | — | US | disclosed |
| EP-3285777-B1 | GLYCAN THERAPEUTICS AND METHODS OF TREATMENT | KALEIDO BIOSCIENCES INC (US) | 2021-06-09 | — | — | EP | disclosed |
| CN-108351609-B | Toner binder and toner | 三洋化成工业株式会社 | 2021-06-01 | — | — | CN | disclosed |
| US-20210137956-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | HERCULES CAPITAL, INC. | 2021-05-13 | — | — | US | disclosed |
| US-20210137967-A1 | SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2021-05-13 | — | — | US | disclosed |
| EP-3615519-B1 | PROPENE RECOVERY BY SCRUBBING WITH A SOLVENT/WATER MIXTURE | BASF SE (DE) | 2021-05-05 | — | — | EP | disclosed |
| US-20210113596-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2021-04-22 | — | — | US | disclosed |
| WO-2021072139-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-04-15 | — | — | WO | disclosed |
| US-20210106525-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2021-04-15 | — | — | US | disclosed |
| US-10960088-B2 | Macrocycles, cobalt and iron complexes of same, and methods of making and using same | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-03-30 | — | — | US | disclosed |
| EP-3489396-B1 | MOLECULE LIBRARY CONSTRUCTED ON THE BASIS OF BACKBONE STRUCTURE OF MICROPROTEIN | AIST (JP) | 2021-03-03 | — | — | EP | disclosed |
| CN-112415871-A | Toner and image forming apparatus | 佳能株式会社 | 2021-02-26 | — | — | CN | disclosed |
| US-20210055667-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2021-02-25 | — | — | US | disclosed |
| CN-110806421-B | NMR detection method for PAMAM and guest small molecule interaction mode | 中国科学院山西煤炭化学研究所 | 2021-02-09 | — | — | CN | disclosed |
| US-10907185-B2 | Enzymatic synthesis of soluble glucan fiber | DUPONT INDUSTRIAL BIOSCIENCES USA, LLC (US) | 2021-02-02 | — | — | US | disclosed |
| US-10894057-B2 | Glycan therapeutic compositions and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2021-01-19 | — | — | US | disclosed |
| CN-108140888-B | Additive for electrolyte | 日清纺控股株式会社 | 2021-01-15 | — | — | CN | disclosed |
| US-20210008530-A1 | CATALYSTS AND METHODS FOR PRODUCING ACETIC ACID FROM METHANE, CARBON MONOXIDE, AND OXYGEN | UNITED STATES DEPARTMENT OF ENERGY | 2021-01-14 | — | — | US | disclosed |
| US-20210002241-A1 | PROPENE RECOVERY BY SCRUBBING WITH A SOLVENT/WATER MIXTURE | BASF SE (DE) | 2021-01-07 | — | — | US | disclosed |
| US-10881676-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2021-01-05 | — | — | US | disclosed |
| US-10882034-B2 | Catalysts for making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2021-01-05 | — | — | US | disclosed |
| CN-112166095-A | Method for producing aromatic compounds from biomass | 巴斯夫欧洲公司 | 2021-01-01 | — | — | CN | disclosed |
| EP-3354282-B1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES INC (US) | 2020-12-30 | — | — | EP | disclosed |
| US-10876074-B2 | Glucan fiber compositions for use in laundry care and fabric care | DUPONT INDUSTRIAL BIOSCIENCES USA, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200390798-A1 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2020-12-17 | — | — | US | disclosed |
| EP-3359656-B1 | COMPOSITIONS AND METHODS COMPRISING THE USE OF EXIGUOBACTERIUM ACETYLICUM AND BACILLUS COAGLUANS ALPHA-GLUCANOTRANSFERASE ENZYMES | DUPONT NUTRITION BIOSCI APS (DK) | 2020-12-16 | — | — | EP | disclosed |
| CN-107366182-B | Paper strength enhancer for high-ash paper, method for producing high-ash paper, and high-ash paper | 荒川化学工业株式会社 | 2020-12-01 | — | — | CN | disclosed |
| US-10844324-B2 | Glucan fiber compositions for use in laundry care and fabric care | DUPONT INDUSTRIAL BIOSCIENCES USA, LLC (US) | 2020-11-24 | — | — | US | disclosed |
| CN-111888369-A | Glycan compositions and uses thereof | 卡莱多生物科技有限公司 | 2020-11-06 | — | — | CN | disclosed |
| US-10822383-B2 | Polypeptides capable of producing glucans having alpha-1,2 branches and use of the same | E I DU PONT DE NEMOURS AND COMPANY (US) | 2020-11-03 | — | — | US | disclosed |
| US-10822574-B2 | Glucan fiber compositions for use in laundry care and fabric care | DUPONT INDUSTRIAL BIOSCIENCES USA, LLC (US) | 2020-11-03 | — | — | US | disclosed |
| EP-3374488-B1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | DUPONT IND BIOSCIENCES USA LLC (US) | 2020-10-14 | — | — | EP | disclosed |
| US-20200317532-A1 | HIGHLY EFFICIENT SOLIDOTHERMAL SYNTHESIS OF ZEOLITIC MATERIALS | BASF SE (DE) | 2020-10-08 | — | — | US | disclosed |
| CN-107532100-B | Lubricant comprising silicon-containing ionic liquid | 日清纺控股株式会社 | 2020-10-02 | — | — | CN | disclosed |
| EP-3487844-B1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2020-09-30 | — | — | EP | disclosed |
| CN-107001308-B | Method for producing 4-azidosulfonyl phthalic anhydride | 陶氏环球技术有限责任公司 | 2020-09-25 | — | — | CN | disclosed |
| US-20200299220-A1 | Methods Of Making Acrylic Acid From Lactic Acid Or Its Derivatives In Liquid Phase | PROCTER & GAMBLE (US) | 2020-09-24 | — | — | US | disclosed |
| US-10774057-B2 | Process for preparing ethene oxide | BASF SE (DE) | 2020-09-15 | — | — | US | disclosed |
| EP-3487846-B1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2020-09-09 | — | — | EP | disclosed |
| CN-109696451-B | NMR determination method of PAMAM (polyamidoamine) on guest small molecule adsorption quantity | 中国科学院山西煤炭化学研究所 | 2020-08-28 | — | — | CN | disclosed |
| EP-3416954-B1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2020-08-19 | — | — | EP | disclosed |
| CN-111556709-A | Methods for improving seed germination and/or plant tolerance to environmental stress | 丹斯塔发酵股份公司 | 2020-08-18 | — | — | CN | disclosed |
| CN-111534503-A | Application of Haloferrila sp | 中国农业大学 | 2020-08-14 | — | — | CN | disclosed |
| CN-106925344-B | Moulded article comprising a Ti-and Zn-containing zeolitic material | 巴斯夫欧洲公司 | 2020-08-14 | — | — | CN | disclosed |
| US-10723687-B2 | Methods of making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2020-07-28 | — | — | US | disclosed |
| US-10717696-B2 | Methods of making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2020-07-21 | — | — | US | disclosed |
| EP-3296381-B1 | LUBRICANT INCLUDING SILICON-CONTAINING IONIC LIQUID | NISSHINBO HOLDINGS INC (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-3679954-A1 | WOUND DRESSING CONTAINING CROSSLINKED GELATIN DERIVATIVE PARTICLES | National Institute for Materials Science (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-3487845-B1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2020-07-08 | — | — | EP | disclosed |
| US-10702542-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| US-20200206382-A1 | WOUND DRESSING CONTAINING CROSSLINKED GELATIN DERIVATIVE PARTICLES | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2020-07-02 | — | — | US | disclosed |
| US-10693127-B2 | Alkaline storage battery | GS YUASA INTERNATIONAL LTD. (JP) | 2020-06-23 | — | — | US | disclosed |
| US-10676451-B2 | Process for purifying propylene oxide | BASF SE (DE) | 2020-06-09 | — | — | US | disclosed |
| US-20200157360-A1 | MODIFIED CONDUCTIVE STRUCTURE AND METHOD FOR PRODUCING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-05-21 | — | — | US | disclosed |
| EP-2667879-B1 | RADIOPAQUE EMBOLIC PARTICLES | ABK BIOMEDICAL INCORPORATED (CA) | 2020-05-20 | — | — | EP | disclosed |
| CN-108425101-B | Coating treatment process for precious metal product | 浙江银之源贵金属有限公司 | 2020-05-19 | — | — | CN | disclosed |
| US-10658700-B2 | Additive for electrolyte solutions | NISSHINBO HOLDINGS INC. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20200131281-A1 | ALPHA-1,3-GLUCAN GRAFT COPOLYMERS | DUPONT INDUSTRIAL BIOSCIENCES USA LLC | 2020-04-30 | — | — | US | disclosed |
| US-10633316-B2 | Methods for converting glycerol to allyl compounds | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2020-04-28 | — | — | US | disclosed |
| CN-111065421-A | Wound dressing containing particles of cross-linked gelatin derivative | 国立研究开发法人物质·材料研究机构 | 2020-04-24 | — | — | CN | disclosed |
| CN-107108537-B | Partial stream distillation | 巴斯夫欧洲公司 | 2020-04-17 | — | — | CN | disclosed |
| US-10619117-B2 | Lubricant including silicon-containing ionic liquid | NISSHINBO HOLDINGS INC. (JP) | 2020-04-14 | — | — | US | disclosed |
| CN-110947427-A | Metal-ligand co-catalysis by nitrogen-hydrogen arm deprotonation/pyridine dearomatization for efficient hydrogen generation from formic acid | 阿卜杜拉国王科技大学 | 2020-04-03 | — | — | CN | disclosed |
| US-20200093851-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2020-03-26 | — | — | US | disclosed |
| US-20200093845-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2020-03-26 | — | — | US | disclosed |
| CN-104105507-B | Nanoparticles for enhancing mucosal penetration or reducing inflammation | 约翰霍普金斯大学 | 2020-03-24 | — | — | CN | disclosed |
| CN-110885809-A | α -L-fucosidase and related biological material and application thereof | 中国农业大学 | 2020-03-17 | — | — | CN | disclosed |
| EP-3615519-A1 | PROPENE RECOVERY BY SCRUBBING WITH A SOLVENT/WATER MIXTURE | BASF SE (DE) | 2020-03-04 | — | — | EP | disclosed |
| EP-3615503-A1 | METHODS OF MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | The Procter and Gamble Company (US) | 2020-03-04 | — | — | EP | disclosed |
| CN-110806421-A | NMR detection method for PAMAM and guest small molecule interaction mode | 中国科学院山西煤炭化学研究所 | 2020-02-18 | — | — | CN | disclosed |
| CN-110770217-A | Propylene recovery by washing with solvent/water mixtures | 巴斯夫欧洲公司 | 2020-02-07 | — | — | CN | disclosed |
| US-10544115-B2 | Process for the preparation of propylene oxide | BASF SE (DE) | 2020-01-28 | — | — | US | disclosed |
| US-10544116-B2 | Process for purifying propylene oxide | BASF SE (DE) | 2020-01-28 | — | — | US | disclosed |
| US-10472657-B2 | Enzymatic hydrolysis of disaccharides and oligosaccharides using alpha-glucosidase enzymes | DUPONT INDUSTRIAL BIOSCIENCES USA, LLC (US) | 2019-11-12 | — | — | US | disclosed |
| CN-107561111-B | The NMR spectrum method of cassava syrup is mixed in a kind of quick identification honey | 江苏出入境检验检疫局动植物与食品检测中心 | 2019-11-08 | — | — | CN | disclosed |
| CN-107561111-B | The NMR spectrum method of cassava syrup is mixed in a kind of quick identification honey | 江苏出入境检验检疫局动植物与食品检测中心 | 2019-11-08 | — | — | CN | disclosed |
| EP-3565017-A1 | ELECTROCHEMICAL LIGHT EMITTING CELL | Japan Advanced Institute of Science and Technology (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-20190330171-A1 | A PROCESS FOR PREPARING ETHENE OXIDE | BASF SE (DE) | 2019-10-31 | — | — | US | disclosed |
| US-20190322963-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | Nutrition & Biosciences USA 4, Inc. | 2019-10-24 | — | — | US | disclosed |
| US-20190322634-A1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2019-10-24 | — | — | US | disclosed |
| US-20190316738-A1 | LIGHT-EMITTING ELECTROCHEMICAL CELL | NISSHINBO HOLDINGS INC. (JP) | 2019-10-17 | — | — | US | disclosed |
| EP-3551194-A1 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2019-10-16 | — | — | EP | disclosed |
| US-10435381-B2 | Process for preparing propylene oxide | BASF SE (DE) | 2019-10-08 | — | — | US | disclosed |
| WO-2019191053-A1 | CATALYSTS AND METHODS FOR PRODUCING ACETIC ACID FROM METHANE, CARBON MONOXIDE, AND OXYGEN | UNIVERSITY OF KANSAS (US) | 2019-10-03 | — | — | WO | disclosed |
| US-10428362-B2 | Enzymatic hydrolysis of disaccharides and oligosaccharides using alpha-glucosidase enzymes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190290675-A1 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2019-09-26 | — | — | US | disclosed |
| EP-3212627-B1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2019-09-25 | — | — | EP | disclosed |
| WO-2019178056-A1 | COMPUTATIONAL PLATFORM FOR IN SILICO COMBINATORIAL SEQUENCE SPACE EXPLORATION AND ARTIFICIAL EVOLUTION OF PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-09-19 | — | — | WO | disclosed |
| EP-2990408-B1 | NOVEL WHITENING AGENT | NICHIREI BIOSCIENCES INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-20190279741-A1 | COMPUTATIONAL PLATFORM FOR IN SILICO COMBINATORIAL SEQUENCE SPACE EXPLORATION AND ARTIFICIAL EVOLUTION OF PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-09-12 | — | — | US | disclosed |
| US-20190271701-A1 | METHODS FOR THE ASSESSMENT OF COLORECTAL CANCER AND COLORECTAL POLYPS BY MEASUREMENT OF METABOLITES IN URINE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2019-09-05 | — | — | US | disclosed |
| US-20190240650-A1 | Catalysts For Making Acrylic Acid From Lactic Acid Or Its Derivatives In Liquid Phase | PROCTER & GAMBLE (US) | 2019-08-08 | — | — | US | disclosed |
| US-20190231745-A1 | INHIBITORS OF T CELL RECEPTOR AND USES THEREOF | CONSEJO SUPERIOR INVESTIGACION (ES) | 2019-08-01 | — | — | US | disclosed |
| US-10361434-B2 | Binder resin for nonaqueous secondary battery electrode, binder resin composition for nonaqueous secondary battery electrode slurry composition for nonaqueous secondary battery electrode, electrode for nonaqueous secondary battery, and nonaqueous secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-23 | — | — | US | disclosed |
| US-10351633-B2 | Enzymatic synthesis of soluble glucan fiber | E I DU PONT DE NEMOURS AND COMPANY (US) | 2019-07-16 | — | — | US | disclosed |
| US-20190210989-A1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2019-07-11 | — | — | US | disclosed |
| EP-2956433-B1 | DIRECT CARBON DIOXIDE HYDROGENATION TO FORMIC ACID IN ACIDIC MEDIA | EOS HOLDING SA (CH) | 2019-06-19 | — | — | EP | disclosed |
| US-10316007-B2 | Part-stream distillation | BASF SE (DE) | 2019-06-11 | — | — | US | disclosed |
| US-10314853-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2019-06-11 | — | — | US | disclosed |
| US-20190169149-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2019-06-06 | — | — | US | disclosed |
| EP-3490705-A1 | CATALYSTS FOR MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | The Procter and Gamble Company (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-3490968-A1 | METHODS OF MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | The Procter & Gamble Company (US) | 2019-06-05 | — | — | EP | disclosed |
| US-10307744-B2 | Catalysts for making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2019-06-04 | — | — | US | disclosed |
| US-10307745-B2 | Catalysts for making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2019-06-04 | — | — | US | disclosed |
| EP-3487846-A1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2019-05-29 | — | — | EP | disclosed |
| EP-3487844-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2019-05-29 | — | — | EP | disclosed |
| EP-3487845-A1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2019-05-29 | — | — | EP | disclosed |
| EP-3489396-A1 | MOLECULE LIBRARY CONSTRUCTED ON THE BASIS OF BACKBONE STRUCTURE OF MICROPROTEIN | National Institute of Advanced Industrial Science and Technology (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-10300469-B1 | Metal-ligand cooperative catalysis through N-H arm deprotonation/pyridine dearomatiztion for efficient hydrogen generation from formic acid | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2019-05-28 | — | — | US | disclosed |
| EP-3484861-A1 | A PROCESS FOR PREPARING ETHENE OXIDE | BASF SE (DE) | 2019-05-22 | — | — | EP | disclosed |
| CN-107561110-B | A kind of discrimination method being used for chaste honey, rape honey and acacia honey based on nuclear magnetic resonance technique | 江苏出入境检验检疫局动植物与食品检测中心 | 2019-05-10 | — | — | CN | disclosed |
| CN-107561110-B | A kind of discrimination method being used for chaste honey, rape honey and acacia honey based on nuclear magnetic resonance technique | 江苏出入境检验检疫局动植物与食品检测中心 | 2019-05-10 | — | — | CN | disclosed |
| US-20190136153-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | Nutrition & Biosciences USA 4, Inc. | 2019-05-09 | — | — | US | disclosed |
| US-10267800-B2 | Methods for the assessment of colorectal cancer and colorectal polyps by measurement of metabolites in urine | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2019-04-23 | — | — | US | disclosed |
| US-20190091249-A1 | GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2019-03-28 | — | — | US | disclosed |
| CN-107300565-B | The NMR spectrum method of rice syrup is mixed in a kind of quick identification honey | 江苏出入境检验检疫局动植物与食品检测中心 | 2019-03-19 | — | — | CN | disclosed |
| US-20190077779-A1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2019-03-14 | — | — | US | disclosed |
| EP-3024579-B1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2019-03-13 | — | — | EP | disclosed |
| US-20190047963-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2019-02-14 | — | — | US | disclosed |
| US-20190048376-A1 | ENZYMATIC HYDROLYSIS OF DISACCHARIDES AND OLIGOSACCHARIDES USING ALPHA-GLUCOSIDASE ENZYMES | Nutrition & Biosciences USA 4, Inc. | 2019-02-14 | — | — | US | disclosed |
| EP-3240782-B1 | PROCESS FOR PRODUCING 4-AZIDOSULFONYLPHTHALIC ANHYDRIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-01-30 | — | — | EP | disclosed |
| WO-2019010216-A1 | ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2019-01-10 | — | — | WO | disclosed |
| EP-2989183-B1 | CYCLIC ORTHO ESTER FUEL ADDITIVE | AIRBUS OPERATIONS LTD (GB) | 2019-01-02 | — | — | EP | disclosed |
| EP-3416954-A1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2018-12-26 | — | — | EP | disclosed |
| US-10155824-B2 | Carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof and/or production method for carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof | KEWPIE CORPORATION (JP) | 2018-12-18 | — | — | US | disclosed |
| CN-108872289-A | Manuka honey discrimination method based on nuclear magnetic resonance technique | 江苏出入境检验检疫局动植物与食品检测中心 | 2018-11-23 | — | — | CN | disclosed |
| US-10125162-B2 | Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates | BRANDEIS UNIVERSITY (US) | 2018-11-13 | — | — | US | disclosed |
| US-20180312781-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | Nutrition & Biosciences USA 4, Inc. | 2018-11-01 | — | — | US | disclosed |
| WO-2018200253-A1 | METHODS OF MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | THE PROCTER & GAMBLE COMPANY (US) | 2018-11-01 | — | — | WO | disclosed |
| WO-2018197234-A1 | PROPENE RECOVERY BY SCRUBBING WITH A SOLVENT/WATER MIXTURE | BASF SE (DE) | 2018-11-01 | — | — | WO | disclosed |
| US-20180296582-A1 | MICROBIOME REGULATORS AND RELATED USES THEREOF | HERCULES CAPITAL, INC. | 2018-10-18 | — | — | US | disclosed |
| US-20180291311-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | Nutrition & Biosciences USA 4, Inc. | 2018-10-11 | — | — | US | disclosed |
| US-20180282385-A1 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA-1,2 BRANCHES AND USE OF THE SAME | Nutrition & Biosciences USA 4, Inc. | 2018-10-04 | — | — | US | disclosed |
| EP-3379945-A1 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA-1,2 BRANCHES AND USE OF THE SAME | E. I. du Pont de Nemours and Company (US) | 2018-10-03 | — | — | EP | disclosed |
| CN-108614000-A | Manuka honey discrimination method based on SIMCA models | 江苏出入境检验检疫局动植物与食品检测中心 | 2018-10-02 | — | — | CN | disclosed |
| US-20180273999-A1 | ENZYMATIC HYDROLYSIS OF DISACCHARIDES AND OLIGOSACCHARIDES USING ALPHA-GLUCOSIDASE ENZYMES | Nutrition & Biosciences USA 4, Inc. | 2018-09-27 | — | — | US | disclosed |
| US-20180265852-A1 | Compositions and Methods Comprising the Use of Exiguobacterium Acetylicum and Bacillus Coagluans Alpha-Glucanotransferase Enzymes | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2018-09-20 | — | — | US | disclosed |
| US-20180269529-A1 | ADDITIVE FOR ELECTROLYTE SOLUTIONS | NISSHINBO HOLDINGS INC. (JP) | 2018-09-20 | — | — | US | disclosed |
| EP-3374400-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | E. I. du Pont de Nemours and Company (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3374488-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | E. I. du Pont de Nemours and Company (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3374401-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | E. I. du Pont de Nemours and Company (US) | 2018-09-19 | — | — | EP | disclosed |
| WO-2018165656-A1 | SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2018-09-13 | — | — | WO | disclosed |
| US-20180235987-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | HERCULES CAPITAL, INC. | 2018-08-23 | — | — | US | disclosed |
| US-10053439-B2 | Catalyst system for preparing propylene oxide | BASF SE (DE) | 2018-08-21 | — | — | US | disclosed |
| US-10056638-B2 | Phosphonium cations and polymers incorporating them | UNIVERSITY OF DELAWARE (US) | 2018-08-21 | — | — | US | disclosed |
| EP-2910558-B1 | IONIC LIQUID | NISSHINBO HOLDINGS INC (JP) | 2018-08-08 | — | — | EP | disclosed |
| EP-3355400-A1 | ADDITIVE FOR ELECTROLYTE SOLUTIONS | Nisshinbo Holdings Inc. (JP) | 2018-08-01 | — | — | EP | disclosed |
| EP-3354282-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-2545090-B1 | RAFT AQUEOUS POLYMERIZATION OF BLOCK POLYMERS | UNIV SHEFFIELD (GB) | 2018-07-11 | — | — | EP | disclosed |
| US-10005751-B2 | Process for producing 4-azidosulfonylphthalic anhydride | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-26 | — | — | US | disclosed |
| EP-3334437-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | Kaleido Biosciences, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| WO-2018106845-A1 | GLYCAN POLYMERS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2018-06-14 | — | — | WO | disclosed |
| EP-3024580-B1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2018-06-13 | — | — | EP | disclosed |
| US-9988657-B2 | Enzymatic hydrolysis of disaccharides and oligosaccharides using alpha-glucosidase enzymes | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-06-05 | — | — | US | disclosed |
| US-20180147222-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2018-05-31 | — | — | US | disclosed |
| US-20180147221-A1 | GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2018-05-31 | — | — | US | disclosed |
| US-20180148400-A1 | Methods Of Making Acrylic Acid From Lactic Acid Or Its Derivatives In Liquid Phase | THE PROCTER & GAMBLE COMPANY | 2018-05-31 | — | — | US | disclosed |
| EP-3024578-B1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2018-05-30 | — | — | EP | disclosed |
| US-9982284-B2 | Enzymatic hydrolysis of disaccharides and oligosaccharides using alpha-glucosidase enzymes | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-29 | — | — | US | disclosed |
| US-20180134979-A1 | LUBRICANT INCLUDING SILICON-CONTAINING IONIC LIQUID | NISSHINBO HOLDINGS INC. (JP) | 2018-05-17 | — | — | US | disclosed |
| US-20180133705-A1 | Catalysts For Making Acrylic Acid From Lactic Acid Or Its Derivatives In Liquid Phase | FRIEDRICH ALEXANDER UNIVERSITAT ERLANGEN NURNBERG (DE) | 2018-05-17 | — | — | US | disclosed |
| US-9943838-B2 | Regeneration of a titanium containing zeolite | BASF SE (DE) | 2018-04-17 | — | — | US | disclosed |
| EP-3296381-A1 | LUBRICANT INCLUDING SILICON-CONTAINING IONIC LIQUID | Nisshinbo Holdings Inc. (JP) | 2018-03-21 | — | — | EP | disclosed |
| WO-2018044234-A1 | CYSTEINE-RICH POLYPEPTIDES AND CONJUGATES AND METHODS OF USING THE SAME | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-03-08 | — | — | WO | disclosed |
| US-9908961-B2 | Vinyl alcohol-based graft polymer, method for producing same, and ion-exchange membrane using same | KURARAY CO., LTD. (JP) | 2018-03-06 | — | — | US | disclosed |
| EP-3285777-A2 | GLYCAN THERAPEUTICS AND METHODS OF TREATMENT | Kaleido Biosciences, Inc. (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-3285778-A2 | MICROBIOME REGULATORS AND RELATED USES THEREOF | Kaleido Biosciences, Inc. (US) | 2018-02-28 | — | — | EP | disclosed |
| US-9901595-B2 | Glycan therapeutics for reducing blood ammonia | KALEIDO BIOSCIENCES, INC. (US) | 2018-02-27 | — | — | US | disclosed |
| US-20180049457-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | DANISCO SWEETENERS OY (FI) | 2018-02-22 | — | — | US | disclosed |
| EP-3283535-A2 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | Cornell University (US) | 2018-02-21 | — | — | EP | disclosed |
| US-9897611-B2 | Molecule library constructed on the basis of backbone structure of microprotein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2018-02-20 | — | — | US | disclosed |
| WO-2018022828-A1 | CATALYSTS FOR MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-01 | — | — | WO | disclosed |
| US-20180029026-A1 | Catalysts For Making Acrylic Acid From Lactic Acid Or Its Derivatives In Liquid Phase | Friedrich Alexander Universitat Erlangen-Nurnberg (DE) | 2018-02-01 | — | — | US | disclosed |
| WO-2018022826-A1 | METHODS OF MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-01 | — | — | WO | disclosed |
| US-20180029969-A1 | Methods Of Making Acrylic Acid From Lactic Acid Or Its Derivatives In Liquid Phase | THE PROCTER & GAMBLE COMPANY | 2018-02-01 | — | — | US | disclosed |
| WO-2018015435-A1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2018-01-25 | — | — | WO | disclosed |
| WO-2018015430-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2018-01-25 | — | — | WO | disclosed |
| WO-2018015434-A1 | A PROCESS FOR PURIFYING PROPYLENE OXIDE | BASF SE (DE) | 2018-01-25 | — | — | WO | disclosed |
| WO-2018011280-A1 | A PROCESS FOR PREPARING ETHENE OXIDE | BASF SE (DE) | 2018-01-18 | — | — | WO | disclosed |
| CN-107561110-A | A kind of discrimination method for being used for chaste honey, rape honey and acacia honey based on nuclear magnetic resonance technique | 江苏出入境检验检疫局动植物与食品检测中心 | 2018-01-09 | — | — | CN | disclosed |
| CN-107561111-A | The NMR spectrum method of cassava syrup is mixed in a kind of quick discriminating honey | 江苏出入境检验检疫局动植物与食品检测中心 | 2018-01-09 | — | — | CN | disclosed |
| US-20170369464-A1 | Process for Producing 4-Azidosulfonylphthalic Anhydride | DOW GLOBAL TECHNOLOGIES LLC | 2017-12-28 | — | — | US | disclosed |
| EP-2911167-B1 | ELECTROLYTE SALT AND ELECTROLYTE FOR ELECTRICITY STORAGE DEVICE, AND ELECTRICITY STORAGE DEVICE | NISSHINBO HOLDINGS INC (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-3240782-A1 | PROCESS FOR PRODUCING 4-AZIDOSULFONYLPHTHALIC ANHYDRIDE | Dow Global Technologies LLC (US) | 2017-11-08 | — | — | EP | disclosed |
| US-20170314050-A9 | ENZYMATIC HYDROLYSIS OF DISACCHARIDES AND OLIGOSACCHARIDES USING ALPHA-GLUCOSIDASE ENZYMES | Nutrition & Biosciences USA 4, Inc. | 2017-11-02 | — | — | US | disclosed |
| EP-2572193-B1 | METHODS FOR THE ASSESSMENT OF COLORECTAL CANCER AND COLORECTAL POLYPS BY MEASUREMENT OF METABOLITES IN URINE | UNIV ALBERTA (CA) | 2017-11-01 | — | — | EP | disclosed |
| US-9802912-B2 | Cyclic ortho ester fuel additive | AIRBUS OPERATIONS LIMITED (GB) | 2017-10-31 | — | — | US | disclosed |
| CN-107300565-A | The NMR spectrum method of rice syrup is mixed in a kind of quick discriminating honey | 江苏出入境检验检疫局动植物与食品检测中心 | 2017-10-27 | — | — | CN | disclosed |
| US-20170298034-A1 | CATALYST SYSTEM FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2017-10-19 | — | — | US | disclosed |
| WO-2017165956-A1 | METABOLOMICS ANALYSIS OF RENAL CELL CARCINOMA | UTI LIMITED PARTNERSHIP (CA) | 2017-10-05 | — | — | WO | disclosed |
| US-20170281541-A1 | LIPOSOME-BASED MUCUS-PENETRATING PARTICLES FOR MUCOSAL DELIVERY | KENNEDY KRIEGER INSTITUTE, INC. | 2017-10-05 | — | — | US | disclosed |
| US-9774038-B2 | Binder resin for nonaqueous secondary battery electrode, binder resin composition for nonaqueous secondary battery electrode slurry composition for nonaqueous secondary battery electrode, electrode for nonaqueous secondary battery, and nonaqueous secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-09-26 | — | — | US | disclosed |
| EP-3216520-A2 | MOLDING AND PROCESS FOR MAKING MICROPOWDER CONTAINING A ZEOLITIC MWW TYPE MATERIAL CONTAINING TI AND ZN | BASF SE (DE) | 2017-09-13 | — | — | EP | disclosed |
| US-9757480-B2 | Radiopaque embolic particles | ABK BIOMEDICAL INCORPORATED (CA) | 2017-09-12 | — | — | US | disclosed |
| US-9757403-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| EP-3212627-A1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2017-09-06 | — | — | EP | disclosed |
| US-20170246201-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-08-31 | — | — | US | disclosed |
| WO-2017140774-A1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2017-08-24 | — | — | WO | disclosed |
| US-20170244105-A1 | Binder Resin for Nonaqueous Secondary Battery Electrode, Binder Resin Composition for Nonaqueous Secondary Battery Electrode Slurry Composition for Nonaqueous Secondary Battery Electrode, Electrode for Nonaqueous Secondary Battery, and Nonaqueous Secondary Battery | MITSUBISHI RAYON CO., LTD. (JP) | 2017-08-24 | — | — | US | disclosed |
| US-9738666-B2 | Electrolyte salt and electrolyte for electricity storage device, and electricity storage device | NISSHINBO HOLDINGS, INC. (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9738616-B2 | Process for preparing propylene oxide | BASF SE (DE) | 2017-08-22 | — | — | US | disclosed |
| US-9732054-B2 | Part-stream distillation | BASF SE (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9725428-B2 | Process for preparing propylene oxide | BASF SE (DE) | 2017-08-08 | — | — | US | disclosed |
| US-20170218093-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | Nutrition & Biosciences USA 4, Inc. | 2017-08-03 | — | — | US | disclosed |
| US-20170204442-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | DANISCO SWEETENERS OY (FI) | 2017-07-20 | — | — | US | disclosed |
| US-20170198323-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | DANISCO SWEETENERS OY (FI) | 2017-07-13 | — | — | US | disclosed |
| US-20170198322-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | DANISCO SWEETENERS OY (FI) | 2017-07-13 | — | — | US | disclosed |
| US-20170198324-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | Nutrition & Biosciences USA 4, Inc. | 2017-07-13 | — | — | US | disclosed |
| US-9688648-B2 | Process for the preparation of propylene oxide | BASF SE (DE) | 2017-06-27 | — | — | US | disclosed |
| EP-2787564-B1 | BINDER RESIN FOR NONAQUEOUS SECONDARY BATTERY ELECTRODE, BINDER RESIN COMPOSITION FOR NONAQUEOUS SECONDARY BATTERY ELECTRODE, SLURRY COMPOSITION FOR NONAQUEOUS SECONDARY BATTERY ELECTRODE, ELECTRODE FOR NONAQUEOUS SECONDARY BATTERY, AND NONAQUEOUS SECONDARY BATTERY | MITSUBISHI RAYON CO (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-20170151269-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-06-01 | — | — | US | disclosed |
| US-20170151268-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | HERCULES CAPITAL, INC. | 2017-06-01 | — | — | US | disclosed |
| WO-2017091533-A1 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA-1,2 BRANCHES AND USE OF THE SAME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-06-01 | — | — | WO | disclosed |
| US-20170149080-A1 | PHOSPHONIUM CATIONS AND POLYMERS INCORPORATING THEM | UNIVERSITY OF DELAWARE (US) | 2017-05-25 | — | — | US | disclosed |
| WO-2017083228-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017083229-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017083226-A1 | GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-05-18 | — | — | WO | disclosed |
| EP-2812115-B1 | MICROPOWDER AND MOLDING CONTAINING A ZEOLITIC MATERIAL CONTAINING TI AND ZN | BASF SE (DE) | 2017-05-17 | — | — | EP | disclosed |
| WO-2017062687-A1 | COMPOSITIONS AND METHODS COMPRISING THE USE OF EXIGUOBACTERIUM ACETYLICUM AND BACILLUS COAGLUANS α-GLUCANOTRANSFERASE ENZYMES | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2017-04-13 | — | — | WO | disclosed |
| EP-3149184-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. du Pont de Nemours and Company (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-3149183-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. du Pont de Nemours and Company (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-3149181-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. du Pont de Nemours and Company (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-3149182-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. du Pont de Nemours and Company (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-3149185-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. du Pont de Nemours and Company (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-3149186-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. du Pont de Nemours and Company (US) | 2017-04-05 | — | — | EP | disclosed |
| US-9611335-B2 | Polymer synthesis | UNIVERSITY OF SHEFFIELD (GB) | 2017-04-04 | — | — | US | disclosed |
| US-9611344-B2 | Vinyl alcohol polymer, method for producing same, and composition and coating agent containing vinyl alcohol polymer | KURARAY CO., LTD. (JP) | 2017-04-04 | — | — | US | disclosed |
| WO-2017046037-A1 | NANOPARTICLES LOADED WITH ACTIVE INGREDIENTS, THEIR PROCESS OF PREPARATION AND THEIR USES | ONXEO (FR) | 2017-03-23 | — | — | WO | disclosed |
| US-20170071866-A1 | NANOPARTICLES LOADED WITH ACTIVE INGREDIENTS, THEIR PROCESS OF PREPARATION, AND THEIR USES | ONXEO S.A. (FR) | 2017-03-16 | — | — | US | disclosed |
| EP-2755966-B1 | BIMETALLIC CATALYSTS FOR CO2 HYDROGENATION AND H2 GENERATION FROM FORMIC ACID AND/OR SALTS THEREOF | BROOKHAVEN SCIENCE ASS LLC (US) | 2017-03-15 | — | — | EP | disclosed |
| WO-2017035412-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| EP-2803681-B1 | VINYL ALCOHOL POLYMER AND METHOD FOR PRODUCING SAME, AND COMPOSITION AND COATING AGENT CONTAINING VINYL ALCOHOL POLYMER | KURARAY CO (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20170033351-A1 | ALKALINE STORAGE BATTERY | KYOTO UNIVERSITY (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20160362387-A1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2016-12-15 | — | — | US | disclosed |
| US-20160332152-A1 | REGENERATION OF A TITANIUM CONTAINING ZEOLITE | BASF SE (DE) | 2016-11-17 | — | — | US | disclosed |
| US-9492473-B2 | Glycan therapeutics and related methods thereof | KALEIDO BIOSCIENCES, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| US-9492368-B2 | External preparation for skin | Hayashibara Co., Ltd. (JP) | 2016-11-15 | — | — | US | disclosed |
| WO-2016172658-A2 | MICROBIOME REGULATORS AND RELATED USES THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016172657-A2 | GLYCAN THERAPEUTICS AND METHODS OF TREATMENT | KALEIDO BIOSCIENCES, INC. (US) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016168468-A2 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | CORNELL UNIVERSITY (US) | 2016-10-20 | — | — | WO | disclosed |
| EP-3077109-A1 | METAL-LIGAND COOPERATIVE CATALYSIS THROUGH N-H ARM DEPROTONATION/PYRIDINE DEAROMATIZTION FOR EFFICIENT HYDROGEN GENERATION FROM FORMIC ACID | King Abdullah University Of Science And Technology (SA) | 2016-10-12 | — | — | EP | disclosed |
| EP-3071235-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2016-09-28 | — | — | EP | disclosed |
| CN-105967265-A | Sewage treating agent containing microbial strains and preparation method | 含山县科宇环境工程有限公司 | 2016-09-28 | — | — | CN | disclosed |
| EP-2671565-B1 | EXTERNAL PREPARATION FOR SKIN | HAYASHIBARA CO (JP) | 2016-09-21 | — | — | EP | disclosed |
| EP-2730582-B1 | IONIC LIQUID | NISSHINBO HOLDINGS INC (JP) | 2016-09-07 | — | — | EP | disclosed |
| US-20160244769-A1 | MICROBIAL HEXOSE FORMATION | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2016-08-25 | — | — | US | disclosed |
| US-20160244534-A1 | CARBOXYMETHYL-GROUP-CONTAINING MODIFIED HYALURONIC ACID AND/OR SALT THEREOF AND/OR PRODUCTION METHOD FOR CARBOXYMETHYL-GROUP-CONTAINING MODIFIED HYALURONIC ACID AND/OR SALT THEREOF | KEWPIE CORPORATION (JP) | 2016-08-25 | — | — | US | disclosed |
| WO-2015130883-A9 | ENZYMATIC HYDROLYSIS OF DISACCHARIDES AND OLIGOSACCHARIDES USING ALPHA-GLUCOSIDASE ENZYMES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-08-18 | — | — | WO | disclosed |
| EP-3056519-A1 | CARBOXYMETHYL-GROUP-CONTAINING MODIFIED HYALURONIC ACID AND/OR SALT THEREOF AND/OR PRODUCTION METHOD FOR CARBOXYMETHYL-GROUP-CONTAINING MODIFIED HYALURONIC ACID AND/OR SALT THEREOF | Kewpie Corporation (JP) | 2016-08-17 | — | — | EP | disclosed |
| US-20160228581-A1 | MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2016-08-11 | — | — | US | disclosed |
| WO-2016122889-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| US-20160213702-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| US-9399613-B2 | Direct carbon dioxide hydrogenation to formic acid in acidic media | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2016-07-26 | — | — | US | disclosed |
| EP-3043828-A1 | MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME | The Research Foundation for the State University of New York (US) | 2016-07-20 | — | — | EP | disclosed |
| WO-2016109389-A1 | PROCESS FOR PRODUCING 4-AZIDOSULFONYLPHTHALIC ANHYDRIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-07-07 | — | — | WO | disclosed |
| US-20160185741-A1 | PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2016-06-30 | — | — | US | disclosed |
| US-20160176834-A1 | PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2016-06-23 | — | — | US | disclosed |
| US-20160176835-A1 | PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2016-06-23 | — | — | US | disclosed |
| EP-3024581-A1 | REGENERATION OF A TITANIUM CONTAINING ZEOLITE | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-3024579-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-3024578-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-3024580-A1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| WO-2016066629-A1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2016-05-06 | — | — | WO | disclosed |
| US-9327989-B2 | Compositions, systems and methods for separating ethanol from water and methods of making compositions for separating ethanol from water | Algenol Biotech LLC (US) | 2016-05-03 | — | — | US | disclosed |
| US-20160115140-A1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2016-04-28 | — | — | US | disclosed |
| US-9296715-B2 | Micropowder and molding containing a zeolitic material containing Ti and Zn | BASF SE (DE) | 2016-03-29 | — | — | US | disclosed |
| US-9296714-B2 | Micropowder and molding containing a zeolitic material containing Ti and Zn | BASF SE (DE) | 2016-03-29 | — | — | US | disclosed |
| US-9290381-B2 | Functionalized single-walled nanotubes and methods thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2016-03-22 | — | — | US | disclosed |
| US-20160068504-A1 | CYCLIC ORTHO ESTER FUEL ADDITIVE | AIRBUS OPERATIONS LIMITED (GB) | 2016-03-10 | — | — | US | disclosed |
| WO-2016036735-A1 | LIPOSOME-BASED MUCUS-PENETRATING PARTICLES FOR MUCOSAL DELIVERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-03-10 | — | — | WO | disclosed |
| EP-2991970-A1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2016-03-09 | — | — | EP | disclosed |
| EP-2990408-A1 | NOVEL WHITENING AGENT | Nichirei Biosciences Inc. (JP) | 2016-03-02 | — | — | EP | disclosed |
| US-20160051690-A1 | METHODS FOR THE DEVELOPMENT OF VACCINES BASED ON OLIGOSACCHARIDE-OLIGONUCLEOTIDE CONJUGATES | UNIV BRANDEIS (US) | 2016-02-25 | — | — | US | disclosed |
| US-20160016875-A1 | DIRECT CARBON DIOXIDE HYDROGENATION TO FORMIC ACID IN ACIDIC MEDIA | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2016-01-21 | — | — | US | disclosed |
| US-20150377899-A1 | MOLECULE LIBRARY CONSTRUCTED ON THE BASIS OF BACKBONE STRUCTURE OF MICROPROTEIN | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2015-12-31 | — | — | US | disclosed |
| US-9221847-B2 | Ionic liquid | NISSHINBO HOLDINGS INC. (JP) | 2015-12-29 | — | — | US | disclosed |
| EP-2956433-A1 | DIRECT CARBON DIOXIDE HYDROGENATION TO FORMIC ACID IN ACIDIC MEDIA | EOS Holding SA (CH) | 2015-12-23 | — | — | EP | disclosed |
| US-20150360962-A1 | Compositions, Systems And Methods For Separating Ethanol From Water And Methods Of Making Compositions For Separating Ethanol From Water | Algenol Biotech LLC (US) | 2015-12-17 | — | — | US | disclosed |
| WO-2015183729-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183722-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183714-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183721-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183726-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183724-A1 | ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| EP-2940197-A1 | MOLECULE LIBRARY CONSTRUCTED ON THE BASIS OF BACKBONE STRUCTURE OF MICROPROTEIN | National Institute of Advanced Industrial Science and Technology (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-20150291633-A1 | ELECTROLYTE SALT AND ELECTROLYTE FOR ELECTRICITY STORAGE DEVICE, AND ELECTRICITY STORAGE DEVICE | NISSHINBO HOLDINGS INC. (JP) | 2015-10-15 | — | — | US | disclosed |
| EP-2930193-A1 | VINYL ALCOHOL-BASED GRAFT POLYMER, METHOD FOR PRODUCING SAME, AND ION-EXCHANGE MEMBRANE USING SAME | Kuraray Co., Ltd. (JP) | 2015-10-14 | — | — | EP | disclosed |
| US-20150266906-A1 | IONIC LIQUID | NISSHINBO HOLDINGS INC. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150259457-A1 | VINYL ALCOHOL-BASED GRAFT POLYMER, METHOD FOR PRODUCING SAME, AND ION-EXCHANGE MEMBRANE USING SAME | KURARAY CO., LTD. (JP) | 2015-09-17 | — | — | US | disclosed |
| US-9132410-B2 | Compositions, systems and methods for separating ethanol from water and methods of making compositions for separating ethanol from water | Algenol Biotech LLC (US) | 2015-09-15 | — | — | US | disclosed |
| US-20150240279-A1 | ENZYMATIC HYDROLYSIS OF DISACCHARIDES AND OLIGOSACCHARIDES USING ALPHA-GLUCOSIDASE ENZYMES | DU PONT (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150240278-A1 | ENZYMATIC HYDROLYSIS OF DISACCHARIDES AND OLIGOSACCHARIDES USING ALPHA-GLUCOSIDASE ENZYMES | Nutrition & Biosciences USA 4, Inc. | 2015-08-27 | — | — | US | disclosed |
| EP-2911167-A1 | ELECTROLYTE SALT AND ELECTROLYTE FOR ELECTRICITY STORAGE DEVICE, AND ELECTRICITY STORAGE DEVICE | Nisshinbo Holdings Inc. (JP) | 2015-08-26 | — | — | EP | disclosed |
| EP-2910558-A1 | IONIC LIQUID | Nisshinbo Holdings Inc. (JP) | 2015-08-26 | — | — | EP | disclosed |
| US-20150216993-A1 | MULTIFUNCTIONAL SMALL MOLECULES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2015-08-06 | — | — | US | disclosed |
| US-9095846-B2 | Bimetallic catalysts for CO2 hydrogenation and H2 generation from formic acid and/or salts thereof | BROOKHAVEN SCIENCE ASSOCIATES, LLC (US) | 2015-08-04 | — | — | US | disclosed |
| US-9090640-B2 | Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof | WAKE FOREST UNIVERSITY | 2015-07-28 | — | — | US | disclosed |
| US-20150203518-A1 | IONIC LIQUID | NISSHINBO HOLDINGS, INC. (JP) | 2015-07-23 | — | — | US | disclosed |
| US-9080169-B2 | Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates | BRANDEIS UNIVERSITY (US) | 2015-07-14 | — | — | US | disclosed |
| US-20150182940-A1 | Compositions, Systems And Methods For Separating Ethanol From Water And Methods Of Making Compositions For Separating Ethanol From Water | ALGENOL BIOFUELS INC. (US) | 2015-07-02 | — | — | US | disclosed |
| WO-2015083007-A1 | METAL-LIGAND COOPERATIVE CATALYSIS THROUGH N-H ARM DEPROTONATION/PYRIDINE DEAROMATIZTION FOR EFFICIENT HYDROGEN GENERATION FROM FORMIC ACID | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2015-06-11 | — | — | WO | disclosed |
| US-9023813-B2 | Synthesis and use of glycoside derivatives of propofol | NuTek Pharma Ltd. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9017692-B2 | Antimicrobial agent, bacterial strain, biosynthesis, and methods of use | OHIO STATE INNOVATION FOUNDATION (US) | 2015-04-28 | — | — | US | disclosed |
| US-20150087852-A1 | FUNCTIONALIZED SINGLE-WALLED NANOTUBES AND METHODS THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2015-03-26 | — | — | US | disclosed |
| WO-2015038943-A1 | MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK UNIVERSITY AT BUFFALO (US) | 2015-03-19 | — | — | WO | disclosed |
| WO-2015020537-A1 | A METHOD AND CONTROL SYSTEM FOR OPTIMISING THE QUALITY OF MEAT | AGRESEARCH LIMITED (NZ) | 2015-02-12 | — | — | WO | disclosed |
| WO-2015010990-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2015-01-29 | — | — | WO | disclosed |
| WO-2015010991-A1 | A PROCESS FOR PREPARING PROPYLENE OXIDE | BASF SE (DE) | 2015-01-29 | — | — | WO | disclosed |
| WO-2015010994-A1 | REGENERATION OF A TITANIUM CONTAINING ZEOLITE | BASF SE (DE) | 2015-01-29 | — | — | WO | disclosed |
| WO-2015010992-A1 | A PROCESS FOR THE PREPARATION OF PROPYLENE OXIDE | BASF SE (DE) | 2015-01-29 | — | — | WO | disclosed |
| EP-2812115-A2 | MICROPOWDER AND MOLDING CONTAINING A ZEOLITIC MATERIAL CONTAINING TI AND ZN | BASF SE (DE) | 2014-12-17 | — | — | EP | disclosed |
| US-8906896-B2 | Platinum acridine anti-cancer compounds and methods thereof | WAKE FOREST UNIVERSITY | 2014-12-09 | — | — | US | disclosed |
| US-20140350169-A1 | VINYL ALCOHOL POLYMER, METHOD FOR PRODUCING SAME, AND COMPOSITION AND COATING AGENT CONTAINING VINYL ALCOHOL POLYMER | KURARAY CO., LTD. (JP) | 2014-11-27 | — | — | US | disclosed |
| EP-2803681-A1 | VINYL ALCOHOL POLYMER AND METHOD FOR PRODUCING SAME, AND COMPOSITION AND COATING AGENT CONTAINING VINYL ALCOHOL POLYMER | Kuraray Co., Ltd. (JP) | 2014-11-19 | — | — | EP | disclosed |
| WO-2014177507-A1 | PART-STREAM DISTILLATION | BASF SE (DE) | 2014-11-06 | — | — | WO | disclosed |
| US-20140316101-A1 | ONE-POT SYNTHESIS OF SIBNC PRECERAMIC POLYMER | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2014-10-23 | — | — | US | disclosed |
| US-20140299817-A1 | Bimetallic Catalysts for CO2 Hydrogenation and H2 Generation from Formic Acid and/or Salts Thereof | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (AIST) (JP) | 2014-10-09 | — | — | US | disclosed |
| EP-2787564-A1 | BINDER RESIN FOR NONAQUEOUS SECONDARY BATTERY ELECTRODE, BINDER RESIN COMPOSITION FOR NONAQUEOUS SECONDARY BATTERY ELECTRODE, SLURRY COMPOSITION FOR NONAQUEOUS SECONDARY BATTERY ELECTRODE, ELECTRODE FOR NONAQUEOUS SECONDARY BATTERY, AND NONAQUEOUS SECONDARY BATTERY | Mitsubishi Rayon Co., Ltd. (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-8846558-B2 | Functionalization of the internal surfaces of zeolites with alcohol compounds | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-30 | — | — | US | disclosed |
| US-8846624-B2 | Modified protein polymers | EMORY UNIVERSITY (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140286953-A1 | HEPCIDIN, HEPCIDIN ANTAGONISTS AND METHODS OF USE | AMGEN INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140287308-A1 | Binder Resin for Nonaqueous Secondary Battery Electrode, Binder Resin Composition for Nonaqueous Secondary Battery Electrode Slurry Composition for Nonaqueous Secondary Battery Electrode, Electrode for Nonaqueous Secondary Battery, and Nonaqueous Secondary Battery | MITSUBISHI RAYON CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20140275439-A1 | BIODEGRADABLE POLYMER WITH CONTROLLED BIODEGRADABILITY | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-09-18 | — | — | US | disclosed |
| EP-2770011-A1 | BIODEGRADABLE POLYMER WITH CONTROLLED BIODEGRADABILITY | National Institute of Advanced Industrial Science And Technology (JP) | 2014-08-27 | — | — | EP | disclosed |
| WO-2014125409-A1 | DIRECT CARBON DIOXIDE HYDROGENATION TO FORMIC ACID IN ACIDIC MEDIA | EOS HOLDING SA (CH) | 2014-08-21 | — | — | WO | disclosed |
| EP-2767530-A1 | Direct carbon dioxide hydrogenation to formic acid in acidic media | EOS Holding SA (CH) | 2014-08-20 | — | — | EP | disclosed |
| EP-2755966-A2 | BIMETALLIC CATALYSTS FOR CO2 HYDROGENATION AND H2 GENERATION FROM FORMIC ACID AND/OR SALTS THEREOF | Brookhaven Science Associates LLC (US) | 2014-07-23 | — | — | EP | disclosed |
| US-20140193334-A1 | Targeted Delivery and Prodrug Designs for Platinum-Acridine Anti-Cancer Compounds and Methods Thereof | WAKE FOREST UNIVERSITY | 2014-07-10 | — | — | US | disclosed |
| US-20140171667-A1 | MICROPOWDER AND MOLDING CONTAINING A ZEOLITIC MATERIAL CONTAINING TI AND ZN | BASF SE (DE) | 2014-06-19 | — | — | US | disclosed |
| WO-2014093249-A1 | CO-POLYMER SOIL SUBGRADE BINDER | HANLEY HOWARD J M (QA) | 2014-06-19 | — | — | WO | disclosed |
| US-8722864-B2 | Glycosylated acetaminophen pro-drug analogs | NuTek Pharma Ltd. (US) | 2014-05-13 | — | — | US | disclosed |
| US-8716422-B2 | Anionic charge-dynamic polymers for release of cationic agents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-05-06 | — | — | US | disclosed |
| US-8637693-B2 | Single walled metal oxide nanotubes | PHILLIPS 66 COMPANY (US) | 2014-01-28 | — | — | US | disclosed |
| US-8629250-B2 | Hepcidin, hepcidin antagonists and methods of use | AMGEN INC. (US) | 2014-01-14 | — | — | US | disclosed |
| EP-2671565-A1 | EXTERNAL PREPARATION FOR SKIN | Hayashibara Co., Ltd. (JP) | 2013-12-11 | — | — | EP | disclosed |
| EP-2667879-A2 | RADIOPAQUE EMBOLIC PARTICLES | Dalhousie University (CA) | 2013-12-04 | — | — | EP | disclosed |
| US-20130309188-A1 | EXTERNAL PREPARATION FOR SKIN | Hayashibara Co., Ltd. (JP) | 2013-11-21 | — | — | US | disclosed |
| US-20130295020-A1 | Radiopaque Embolic Particles | DALHOUSIE UNIVERSITY (CA) | 2013-11-07 | — | — | US | disclosed |
| US-8574420-B2 | Ultrathin multilayered films for controlled release of anionic reagents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-11-05 | — | — | US | disclosed |
| EP-2646834-A1 | METHOD FOR EVALUATING THE VITAL PROGNOSIS OF A SUBJECT IN A CRITICAL CONDITION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2013-10-09 | — | — | EP | disclosed |
| US-8551695-B2 | Starch binding domain and use thereof | SIMPSON BIOTECH CO., LTD. (TW) | 2013-10-08 | — | — | US | disclosed |
| US-20130245957-A1 | Magnetic Resonance Spectroscopy of Breast Biopsy to Determine Pathology, Vascularization and Nodal Development | MOUNTFORD CAROLYN E (AU) | 2013-09-19 | — | — | US | disclosed |
| US-20130217640-A1 | GLYCOSYLATED ACETAMINOPHEN PRO-DRUG | NuTek Pharma Ltd. | 2013-08-22 | — | — | US | disclosed |
| WO-2013117536-A2 | MICROPOWDER AND MOLDING CONTAINING A ZEOLITIC MATERIAL CONTAINING TI AND ZN | BASF SE (DE) | 2013-08-15 | — | — | WO | disclosed |
| US-20130204018-A1 | MICROPOWDER AND MOLDING CONTAINING A ZEOLITIC MATERIAL CONTAINING TI AND ZN | BASF SE (DE) | 2013-08-08 | — | — | US | disclosed |
| US-20130164317-A1 | ANTIMICROBIAL AGENT, BACTERIAL STRAIN, BIOSYNTHESIS, AND METHODS OF USE | THE OHIO STATE UNIVERSITY | 2013-06-27 | — | — | US | disclosed |
| WO-2013086003-A1 | ANTIMICROBIAL AGENT, BACTERIAL STRAIN, BIOSYNTHESIS, AND METHODS OF USE | THE OHIO STATE UNIVERSITY (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-2602280-A1 | One-pot synthesis of SiBNC preceramic polymer | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-8450293-B2 | Synthesis and characterization of C8 analogs of c-di-GMP | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-05-28 | — | — | US | disclosed |
| US-20130122055-A1 | Anionic Charge-Dynamic Polymers for Release of Cationic Agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-05-16 | — | — | US | disclosed |
| US-20130116417-A1 | Methods for the Development of Vaccines Based on Oligosaccharide-Oligonucleotide Conjugates | BRANDEIS UNIVERSITY (US) | 2013-05-09 | — | — | US | disclosed |
| EP-2126066-B1 | LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING NOVEL SUBSTRATE SPECIFICITY AND USE THEREOF | CELLECTIS (FR) | 2013-05-01 | — | — | EP | disclosed |
| EP-2580324-A2 | METHODS FOR THE DEVELOPMENT OF VACCINES BASED ON OLIGOSACCHARIDE-OLIGONUCLEOTIDE CONJUGATES | Brandeis University (US) | 2013-04-17 | — | — | EP | disclosed |
| EP-2572193-A1 | METHODS FOR THE ASSESSMENT OF COLORECTAL CANCER AND COLORECTAL POLYPS BY MEASUREMENT OF METABOLITES IN URINE | The Governors Of The University Of Alberta (CA) | 2013-03-27 | — | — | EP | disclosed |
| US-8404487-B2 | determining whether a mammary gland tumor has spread to the lymph nodes, comprising obtaining magnetic resonance spectra of the tissue that contains a tumor and comparing the data with the histopathology provide computerized classification-based diagnosis and prognosis with a very high degree of accuracy | MOUNTFORD CAROLYN E (AU) | 2013-03-26 | — | — | US | disclosed |
| WO-2013040013-A2 | BIMETALLIC CATALYSTS FOR CO2 HYDROGENATION AND H2 GENERATION FROM FORMIC ACID AND/OR SALTS THEREOF | BROOKHAVEN SCIENCE ASSOCIATES, LLC (US) | 2013-03-21 | — | — | WO | disclosed |
| US-20130065320-A1 | METHODS FOR THE ASSESSMENT OF COLORECTAL CANCER AND COLORECTAL POLYPS BY MEASUREMENT OF METABOLITES IN URINE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2013-03-14 | — | — | US | disclosed |
| WO-2013033430-A1 | TARGETED DELIVERY AND PRODRUG DESIGNS FOR PLATINUM-ACRIDINE ANTI-CANCER COMPOUNDS AND METHODS THEREOF | WAKE FOREST SCHOOL OF MEDICINE (US) | 2013-03-07 | — | — | WO | disclosed |
| US-20130046052-A1 | Polymer Synthesis | THE UNIVERSITY OF SHEFFIELD (GB) | 2013-02-21 | — | — | US | disclosed |
| US-20130018176-A1 | METHODS OF PRODUCING HYBRIDOMAS AND MONOCLONAL ANTIBODIES AND ANTIBODIES PRODUCED THEREBY | AMGEN INC. (US) | 2013-01-17 | — | — | US | disclosed |
| EP-2545090-A2 | POLYMER SYNTHESIS | The University Of Sheffield (GB) | 2013-01-16 | — | — | EP | disclosed |
| US-8324333-B2 | Anionic charge-dynamic polymers for release of cationic agents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-12-04 | — | — | US | disclosed |
| US-20120295866-A1 | Synthesis And Use Of Glycoside Pro-Drug Analogs | NuTek Pharma Ltd. | 2012-11-22 | — | — | US | disclosed |
| US-8294974-B2 | Electrochromic material and electrochromic device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-10-23 | — | — | US | disclosed |
| US-20120264702-A1 | Synthesis And Use Of Glycoside Derivatives of Propofol | NuTek Pharma Ltd. | 2012-10-18 | — | — | US | disclosed |
| WO-2012142147-A2 | SYNTHESIS AND USE OF GLYCOSIDE DERIVATIVES OF PROPOFOL | NuTek Pharma Ltd. (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2012142141-A1 | SYNTHESIS AND USE OF GLYCOSIDE PRO-DRUG ANALOGS | NuTek Pharma Ltd. (US) | 2012-10-18 | — | — | WO | disclosed |
| US-20120237937-A1 | METHODS TO DETECT CANCER IN ANIMALS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20120225492-A1 | Starch Binding Domain and Use Thereof | SIMPSON BIOTECH CO., LTD. (TW) | 2012-09-06 | — | — | US | disclosed |
| US-20120197539-A1 | METHODS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENT HEALTH USING METABOLOMICS | SLUPSKY CAROLYN (US) | 2012-08-02 | — | — | US | disclosed |
| WO-2012101524-A2 | RADIOPAQUE EMBOLIC PARTICLES | DALHOUSIE UNIVERSITY (CA) | 2012-08-02 | — | — | WO | disclosed |
| EP-2479209-A1 | PROCESS FOR PRODUCTION OF CURED MOLDED ARTICLE, AND CURED MOLDED ARTICLE | Nippon Shokubai Co., Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172483-A1 | PROCESS FOR PRODUCTION OF CURED MOLDED ARTICLE, AND CURED MOLDED ARTICLE | NIPPON SHOKUBAI CO., LTD (JP) | 2012-07-05 | — | — | US | disclosed |
| WO-2012072682-A1 | METHOD FOR EVALUATING THE VITAL PROGNOSIS OF A SUBJECT IN A CRITICAL CONDITION | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2012-06-07 | — | — | WO | disclosed |
| US-20120065616-A1 | Ultrathin Multilayered Films for Controlled Release of Anionic Reagents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-03-15 | — | — | US | disclosed |
| US-20120039800-A1 | Platinum Acridine Anti-Cancer Compounds And Methods Thereof | WAKE FOREST UNIVERSITY | 2012-02-16 | — | — | US | disclosed |
| US-20120041057-A1 | SYNTHESIS AND CHARACTERIZATION OF C8 ANALOGS OF c-di-GMP | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | disclosed |
| US-20120022012-A1 | Glycosylated Acetaminophen Pro-Drug Analogs | NuTek Pharma Ltd. | 2012-01-26 | — | — | US | disclosed |
| WO-2012012339-A2 | GLYCOSYLATED ACETAMINOPHEN PRO-DRUG ANALOGS | NuTek Pharma Ltd. (US) | 2012-01-26 | — | — | WO | disclosed |
| CN-101336313-B | Methods for the electrolytic production of erythrose or erythritol | DYNAMIC FOOD INGREDIENTS CORP | 2012-01-04 | — | — | CN | disclosed |
| WO-2011156690-A2 | METHODS FOR THE DEVELOPMENT OF VACCINES BASED ON OLIGOSACCHARIDE-OLIGONUCLEOTIDE CONJUGATES | BRANDEIS UNIVERSITY (US) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011143779-A1 | METHODS FOR THE ASSESSMENT OF COLORECTAL CANCER AND COLORECTAL POLYPS BY MEASUREMENT OF METABOLITES IN URINE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2011-11-24 | — | — | WO | disclosed |
| US-20110287031-A1 | Covalently reactive transition state analogs and methods of use thereof | PAUL, SUDHIR, DR. | 2011-11-24 | — | — | US | disclosed |
| US-20110235150-A1 | ELECTROCHROMIC MATERIAL AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| US-20110230672-A1 | SINGLE-WALLED METAL OXIDE NANOTUBES | Georgia Inst. of Tech, Office of Technology Licensing (US) | 2011-09-22 | — | — | US | disclosed |
| WO-2011116080-A1 | SINGLE-WALLED METAL OXIDE NANOTUBES | Georgia Inst. of Tech, Office of Technology Licensing (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011110841-A2 | POLYMER SYNTHESIS | THE UNIVERSITY OF SHEFFIELD (GB) | 2011-09-15 | — | — | WO | disclosed |
| EP-2358203-A1 | PLATINUM ACRIDINE ANTI-CANCER COMPOUNDS AND METHODS THEREOF | Wake Forest University (US) | 2011-08-24 | — | — | EP | disclosed |
| US-7880468-B2 | Method of using G-matrix fourier transformation nuclear magnetic resonance (GFT NMR) spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2011-02-01 | — | — | US | disclosed |
| US-20110020857-A1 | Metabonomic Methods to Assess Health of Skin | HONKONEN ROBERT STEPHEN | 2011-01-27 | — | — | US | disclosed |
| US-7863408-B2 | Body fluid compatible and biocompatible resin | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2011-01-04 | — | — | US | disclosed |
| US-7863304-B2 | Analogs of glycyl-prolyl-glutamate | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2011-01-04 | — | — | US | disclosed |
| WO-2010144876-A1 | METHODS TO DETECT CANCER IN ANIMALS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC (US) | 2010-12-16 | — | — | WO | disclosed |
| US-20100249175-A1 | Dicationic compounds which selectively recognize G-quadruplex DNA | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2010-09-30 | — | — | US | disclosed |
| US-7761242-B2 | Metabonomic methods to assess health of skin | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-20 | — | — | US | disclosed |
| WO-2010073969-A2 | POLYSILOXANE COMPOSITION AND METHOD FOR PRODUCING THE SAME | DOW CORNING TORAY CO., LTD. (JP) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010048499-A1 | PLATINUM ACRIDINE ANTI-CANCER COMPOUNDS AND METHODS THEREOF | WAKE FOREST UNIVERSITY (US) | 2010-04-29 | — | — | WO | disclosed |
| US-20100086533-A1 | LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING NOVEL SUBSTRATE SPECIFICITY AND USE THEREOF | CELLECTIS (FR) | 2010-04-08 | — | — | US | disclosed |
| US-20100048736-A1 | ANIONIC CHARGE-DYNAMIC POLYMERS FOR RELEASE OF CATIONIC AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-25 | — | — | US | disclosed |
| US-20100048880-A1 | Starch Binding Domain and Use Thereof | SIMPSON BIOTECH CO., LTD. (TW) | 2010-02-25 | — | — | US | disclosed |
| US-20100048473-A1 | Modified Protein Polymers | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-25 | — | — | US | disclosed |
| US-20100031452-A1 | AZO DYES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2010-02-11 | — | — | US | disclosed |
| US-7652034-B2 | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | SIDEM PHARMA (LU) | 2010-01-26 | — | — | US | disclosed |
| US-20100016619-A1 | Functionalization of the internal surfaces of zeolites with alcohol compounds | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2010-01-21 | — | — | US | disclosed |
| WO-2010003969-A2 | NEW AZO DYES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2010-01-14 | — | — | WO | disclosed |
| CN-101605809-A | Starch adsorption zone and use thereof | SIMPSON BIOTECH CO LTD (CN) | 2009-12-16 | — | — | CN | disclosed |
| EP-2126066-A1 | LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING NOVEL SUBSTRATE SPECIFICITY AND USE THEREOF | CELLECTIS (FR) | 2009-12-02 | — | — | EP | disclosed |
| EP-2111412-A2 | HEPCIDIN AND HEPCIDIN ANTIBODIES | Amgen, Inc (US) | 2009-10-28 | — | — | EP | disclosed |
| US-7601775-B2 | Fire retardant resin composition, method of its production, shaped articles comprising the same, and silica | NIPPON SHOKUBAI CO., LTD. (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7579373-B2 | Targeted bisplatinum polyamines as pro-drugs: selective release of platinum | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2009-08-25 | — | — | US | disclosed |
| EP-2089421-A1 | STARCH BINDING DOMAIN AND USE THEREOF | Simpson Biotech Co., Ltd. (TW) | 2009-08-19 | — | — | EP | disclosed |
| US-20090180995-A1 | NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX | NATIONAL UNIVERSITY OF SINGAPORE | 2009-07-16 | — | — | US | disclosed |
| EP-1888618-A4 | ANALOGS OF GLYCYL-PROLYL-GLUTAMATE | NEUREN PHARMACEUTICALS LTD (NZ) | 2009-07-15 | — | — | EP | disclosed |
| EP-1913023-A4 | NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX | UNIV SINGAPORE (SG) | 2009-05-13 | — | — | EP | disclosed |
| WO-2009057821-A1 | MICROPARTICLE OF METAL OR METAL OXIDE HAVING SILICON-CONTAINING ORGANIC GROUP, AND METHOD FOR PRODUCING THE SAME | DOW CORNING TORAY CO., LTD. (JP) | 2009-05-07 | — | — | WO | disclosed |
| US-20090115414-A1 | PHASE-SENSITIVELY DETECTED REDUCED DIMENSIONALITY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2009-05-07 | — | — | US | disclosed |
| WO-2009057817-A1 | POLYSILOXANE COMPOSITION AND METHOD FOR PRODUCING THE SAME | DOW CORNING TORAY CO., LTD. (JP) | 2009-05-07 | — | — | WO | disclosed |
| US-7524663-B2 | Covalently reactive transition state analogs and methods of use thereof | PAUL, SUDHIR, DR. | 2009-04-28 | — | — | US | disclosed |
| US-20090105375-A1 | Ultrathin Multilayered Films for Controlled Release of Anionic Reagents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-04-23 | — | — | US | disclosed |
| WO-2009049100-A2 | ULTRATHIN MULTILAYERED FILMS FOR CONTROLLED RELEASE OF ANIONIC REAGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-04-16 | — | — | WO | disclosed |
| US-7476386-B1 | Mixed lipopeptide micelles for inducing an immune response | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-01-13 | — | — | US | disclosed |
| US-20090009166-A1 | METHOD OF USING G-MATRIX FOURIER TRANSFORMATION NUCLEAR MAGNETIC RESONANCE (GFT NMR) SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2009-01-08 | — | — | US | disclosed |
| CN-101336313-A | Methods for the electrolytic production of erythrose or erythritol | DYNAMIC FOOD INGREDIENTS CORP (US) | 2008-12-31 | — | — | CN | disclosed |
| US-7465834-B2 | Bis(dimethylamino)propylthiomethylium bis(trifluoromethanesulfonyl)imide; bis(dimethylamino)ethoxymethylium bis(trifluoromethanesulfonyl)imide; stable liquid state even at low temperatures; good conductivity | KANTO DENKA KOGYO CO., LTD. (JP) | 2008-12-16 | — | — | US | disclosed |
| EP-1989553-A1 | METABONOMIC METHODS TO ASSESS HEALTH OF SKIN | The Procter and Gamble Company (US) | 2008-11-12 | — | — | EP | disclosed |
| US-7432239-B2 | Polyoxyalkylene compound and method for making | CENTRAL MICHIGAN UNIVERSITY BOARD OF TRUSTEES (US) | 2008-10-07 | — | — | US | disclosed |
| WO-2008112154-A2 | METHODS OF USING GENOMIC BIOMARKERS TO PREDICT TUMOR FORMATION | THE HAMNER INSTITUTES FOR HEALTH SCIENCES (US) | 2008-09-18 | — | — | WO | disclosed |
| US-20080219932-A1 | Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement | MOUNTFORD CAROLYN E | 2008-09-11 | — | — | US | disclosed |
| US-20080213277-A1 | Peptide hormone specific monoclonal antibody for use in diagnosis, prognosis, prevention and treatment of blood, cell proliferative, inflammatory, kidney and liver disorders | AMGEN INC. (US) | 2008-09-04 | — | — | US | disclosed |
| WO-2008102198-A1 | LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING NOVEL SUBSTRATE SPECIFICITY AND USE THEREOF | CELLECTIS (FR) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008097461-A2 | HEPCIDIN AND HEPCIDIN ANTIBODIES | AMGEN INC (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-1556437-B1 | ANTISTATIC AGENTS AND POLYMER COMPOSITIONS DERIVED THEREFROM | GEN ELECTRIC (US) | 2008-07-30 | — | — | EP | disclosed |
| US-7402593-B2 | (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine; proton pump inhibitor (PPI) to treat gastro-oesophageal reflux, digestive bleeding and dyspepsia; enantiomer; long duration of action; longer half-life in plasma; oxidation of sulfide followed by salt formation | SIDEM PHARMA (LU) | 2008-07-22 | — | — | US | disclosed |
| US-7396685-B2 | Phase sensitively-detected reduced dimensionality nuclear magnetic resonance spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2008-07-08 | — | — | US | disclosed |
| US-20080145335-A1 | Analogs of Glycyl-Prolyl-Glutamate | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2008-06-19 | — | — | US | disclosed |
| WO-2008052387-A1 | STARCH BINDING DOMAIN AND USE THEREOF | SIMPSON BIOTECH CO., LTD. (CN) | 2008-05-08 | — | — | WO | disclosed |
| US-7365539-B2 | Method of using G-matrix fourier transformation nuclear magnetic resonance (GFT NMR) spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2008-04-29 | — | — | US | disclosed |
| EP-1913023-A1 | NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2008-04-23 | — | — | EP | disclosed |
| WO-2008033847-A2 | MODIFIED PROTEIN POLYMERS | EMORY UNIVERSITY (US) | 2008-03-20 | — | — | WO | disclosed |
| US-7335511-B2 | Magnetic resonance spectroscopy to classify tissue | UNIVERSITY OF SYDNEY (AU) | 2008-02-26 | — | — | US | disclosed |
| EP-1888618-A2 | ANALOGS OF GLYCYL-PROLYL-GLUTAMATE | Neuren Pharmaceuticals Limited (NZ) | 2008-02-20 | — | — | EP | disclosed |
| EP-1427739-A4 | TARGETED BISPLATINUM POLYAMINES AS PRO-DRUGS: SELECTIVE RELEASE OF PLATINUM | UNIV VIRGINIA COMMONWEALTH (US) | 2008-02-13 | — | — | EP | disclosed |
| US-7307184-B2 | Processes for preparing oxazolidinone derivatives of β-hydroxyethlamine compounds and for preparing β-hydroxyethlamine compounds | KANEKA CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-7294733-B2 | Method for preparing formylphosphonic acid | MONSANTO TECHNOLOGY LLC (US) | 2007-11-13 | — | — | US | disclosed |
| US-20070224696-A1 | Metabonomic methods to assess health of skin | PROCTER & GAMBLE COMPANY, THE | 2007-09-27 | — | — | US | disclosed |
| US-20070202604-A1 | Metabonomic methods to assess health of skin | THE PROCTER & GAMBLE COMPANY | 2007-08-30 | — | — | US | disclosed |
| WO-2007096846-A1 | METABONOMIC METHODS TO ASSESS HEALTH OF SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2007-08-30 | — | — | WO | disclosed |
| US-20070179176-A1 | Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy | SIDEM PHARMA (LU) | 2007-08-02 | — | — | US | disclosed |
| CN-101003525-A | Dicationic compounds which selectively recognize G-quadruplex DNA | UNIV NORTH CAROLINA (US) | 2007-07-25 | — | — | CN | disclosed |
| EP-1792613-A2 | Dicationic compounds which selectively recognize G-quadruplex DNA | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2007-06-06 | — | — | EP | disclosed |
| WO-2007018475-A1 | NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2007-02-15 | — | — | WO | disclosed |
| WO-2006127702-A2 | ANALOGS OF GLYCYL-PROLYL-GLUTAMATE | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2006-11-30 | — | — | WO | disclosed |
| US-20060211881-A1 | METHOD FOR PREPARING FORMYLPHOSPHONIC ACID | MONSANTO TECHNOLOGY LLC (US) | 2006-09-21 | — | — | US | disclosed |
| US-20060194832-A1 | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | SIDEM PHARMA S.A. | 2006-08-31 | — | — | US | disclosed |
| US-7091376-B2 | Method for preparing formylphosphonic acid | MONSANTO TECHNOLOGY LLC (US) | 2006-08-15 | — | — | US | disclosed |
| US-20060167164-A1 | Fire retardant resin composition, method of its production, shaped articles comprising the same, and silica | NIPPON SHOKUBAI CO., LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060135784-A1 | PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES | KANEKA CORPORATION | 2006-06-22 | — | — | US | disclosed |
| US-7057066-B2 | Process for producing 3-amino-2-hydroxypropionic acid derivatives | KANEKA CORPORATION (JP) | 2006-06-06 | — | — | US | disclosed |
| US-7034038-B2 | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | SIDEM PHARMA (LU) | 2006-04-25 | — | — | US | disclosed |
| WO-2006010138-A9 | BIOACTIVE CHEMOKINE HETEROMULTIMERS | UNIV MINNESOTA (US) | 2006-03-23 | — | — | WO | disclosed |
| EP-1223856-B1 | MAGNETIC RESONANCE SPECTROSCOPY OF BREAST BIOPSY TO DETERMINE PATHOLOGY, VASCULARIZATION AND NODAL INVOLVEMENT | CA NAT RESEARCH COUNCIL (CA) | 2006-02-08 | — | — | EP | disclosed |
| WO-2006010138-A1 | BIOACTIVE CHEMOKINE HETEROMULTIMERS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2006-01-26 | — | — | WO | disclosed |
| EP-1373307-A4 | COVALENTLY REACTIVE TRANSITION STATE ANALOGS AND METHODS OF USE THEREOF | UNIV TEXAS (US) | 2006-01-25 | — | — | EP | disclosed |
| US-20050256032-A1 | Polyoxyalkylene compound and method for making | MOHANTY DILLIP K | 2005-11-17 | — | — | US | disclosed |
| CN-1656177-A | Fire retardant resin composition, method of its production, shaped articles comprising the same, and silica | NIPPON CATALYTIC CHEM IND (JP) | 2005-08-17 | — | — | CN | disclosed |
| US-20050171002-A1 | Conjugation of a polyoxyalkylene to a peptide, protein, dendrimer or cyclodextrin, by reacting an acrylated polyoxyethylene glycol monomethyl ether with a compound containing amine or mercapto groups; Micheal addition; one reaction step, by-product inhibition | CENTRAL MICHIGAN UNIVERSITY BOARD OF TRUSTEES | 2005-08-04 | — | — | US | disclosed |
| EP-1556437-A1 | ANTISTATIC AGENTS AND POLYMER COMPOSITIONS DERIVED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2005-07-27 | — | — | EP | disclosed |
| US-20050142649-A1 | Covalently reactive transition state analogs and methods of use thereof | PAUL, SUDHIR, DR. | 2005-06-30 | — | — | US | disclosed |
| US-20050119298-A1 | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | SIDEM PHARMA (LU) | 2005-06-02 | — | — | US | disclosed |
| US-6900257-B2 | Antistatic agents and polymer compositions derived therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-05-31 | — | — | US | disclosed |
| US-20050114038-A1 | Method of using G-matrix fourier transformation nuclear magnetic resonance (GFT NMR) spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-05-26 | — | — | US | disclosed |
| US-20050113560-A1 | Body fluid compatible and biocompatible resin | ASAHI KASEI KABUSHIKI KAISHA | 2005-05-26 | — | — | US | disclosed |
| US-20050107683-A1 | Magnetic resonance spectroscopy to classify tissue | SYDNEY, UNIVERSITY OF (AU) | 2005-05-19 | — | — | US | disclosed |
| EP-1530732-A2 | A METHOD OF USING G-MATRIX FOURIER TRANSFORMATION NUCLEAR MAGNETIC RESONANCE (GFT NMR) SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2005-05-18 | — | — | EP | disclosed |
| EP-0562836-B1 | Endo-xyloglucan transferase | TAKARA BIO INC (JP) | 2005-05-18 | — | — | EP | disclosed |
| EP-1507829-A1 | FIRE RETARDANT RESIN COMPOSITION, METHOD OF ITS PRODUCTION, SHAPED ARTICLES COMPRISING THE SAME, AND SILICA | Nippon Shokubai Co., Ltd. (JP) | 2005-02-23 | — | — | EP | disclosed |
| US-6855804-B2 | Covalently reactive transition state analogs and methods of use thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2005-02-15 | — | — | US | disclosed |
| US-20050004044-A1 | Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en-22-one 16-0-(2-0-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-(2-0-acetyl-alpha-L-arabinopyranoside)] or OSW-1 and its derivatives for cancer therapeutics | BOARD OF REGENTS | 2005-01-06 | — | — | US | disclosed |
| US-6835572-B1 | Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement | INSTITUTE FOR MAGNETIC RESONANCE RESEARCH (AU) | 2004-12-28 | — | — | US | disclosed |
| US-6831459-B2 | Method of using G-matrix Fourier transformation nuclear magnetic resonance (GFT NMR) spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2004-12-14 | — | — | US | disclosed |
| US-20040225147-A1 | Method for preparing formylphosphonic acid | MONSANTO COMPANY | 2004-11-11 | — | — | US | disclosed |
| WO-2004091484-A2 | USE OF ORSAPONIN [3BETA, 16BETA, 17 ALPHA-TRIHYDROXYCHOLOST-5-EN22-ONE 16-0-(2-0-4-METHOXYBENZOYL-BETA-D-XYLOPYRANOSYL)-(1->3)-(2-0ACETYL-ALPHA-L-ARABINOPYRANOSIDE)] OR OSW-1 AND ITS DERIVATIVES FOR CANCER THERAPEUTICS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004080409-A2 | USE OF MULTIVALENT GLYCODENDRIMERS TO INHIBIT THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS | THE PENN STATE RESEARCH FOUNDATION (US) | 2004-09-23 | — | — | WO | disclosed |
| US-20040180852-A1 | Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-09-16 | — | — | US | disclosed |
| US-20040181074-A1 | Process for producing oxazolidinone derivative of beta-hydroxyethylamine compound and for producing beta-hydroxyethlamine compound | KANEKA CORPORATION (JP) | 2004-09-16 | — | — | US | disclosed |
| US-6762317-B2 | AMINOMETHYLPHOSPHONIC ACID IS CONTACTED WITH WATER, AN ALCOHOL, A PHENOL AND AN OXIDIZING GAS IN THE PRESENCE OF A CATALYST | MONSANTO COMPANY | 2004-07-13 | — | — | US | disclosed |
| EP-1427739-A1 | TARGETED BISPLATINUM POLYAMINES AS PRO-DRUGS: SELECTIVE RELEASE OF PLATINUM | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1423691-A1 | FLUORESCENCE BASED OXYGEN SENSOR SYSTEMS | 3M Innovative Properties Company (US) | 2004-06-02 | — | — | EP | disclosed |
| US-20040095140-A1 | Phase sensitively-detected reduced dimensionality nuclear magnetic resonance spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | NIH-DEITR | 2004-05-20 | — | — | US | disclosed |
| EP-0640835-B1 | Method for determining sugar chain structure | TAKARA BIO INC (JP) | 2004-04-07 | — | — | EP | disclosed |
| US-20040061497-A1 | Method of using G-matrix Fourier transformation nuclear magnetic resonance (GFT NMR) spectroscopy for rapid chemical shift assignment and secondary structure determination of proteins | NATIONAL INSTITUTES OF HEALTH | 2004-04-01 | — | — | US | disclosed |
| EP-1403257-A1 | PROCESSES FOR PRODUCING OXAZOLIDINONE DERIVATIVE OF BETA-HYDROXYETHYLAMINE COMPOUND AND FOR PRODUCING BETA-HYDROXYETHYLAMINE COMPOUND | KANEKA CORPORATION (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20040049074-A1 | Process for producing 3-amino-2-hydroxypropionic acid derivatives | KANEKA CORPORATION (JP) | 2004-03-11 | — | — | US | disclosed |
| EP-1184380-B1 | Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof | TAKASAGO PERFUMERY CO LTD (JP) | 2004-02-25 | — | — | EP | disclosed |
| WO-2004013218-A1 | ANTISTATIC AGENTS AND POLYMER COMPOSITIONS DERIVED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20040030015-A1 | Antistatic agents and polymer compositions derived therefrom | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2004-02-12 | — | — | US | disclosed |
| WO-2004011909-A2 | PHASE-SENSITIVELY DETECTED REDUCED DIMENSIONALITY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2004-02-05 | — | — | WO | disclosed |
| WO-2004007016-A2 | A METHOD OF USING G-MATRIX FOURIER TRANSFORMATION NUCLEAR MAGNETIC RESONANCE (GFT NMR) SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2004-01-22 | — | — | WO | disclosed |
| EP-1236733-B1 | A process for the preparation of disodium pamidronate | BIOINDUSTRIA LAB ITALIANO MEDI (IT) | 2004-01-21 | — | — | EP | disclosed |
| EP-1373307-A2 | COVALENTLY REACTIVE TRANSITION STATE ANALOGS AND METHODS OF USE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-01-02 | — | — | EP | disclosed |
| US-6664111-B2 | The detector is a solid polymeric matrix, e.g., siloxane, modified by a luminescent platinum group metal phenanthroline chelate complex which is quenchable by oxygen; blood and tissue samples; medical diagnosis; compact; lightweight | 3M INNOVATIVE PROPERTIES COMPANY | 2003-12-16 | — | — | US | disclosed |
| US-6664040-B2 | Complexing to polypeptides; antiproliferation agent | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-16 | — | — | US | disclosed |
| WO-2003099934-A1 | FIRE RETARDANT RESIN COMPOSITION, METHOD OF ITS PRODUCTION, SHAPED ARTICLES COMPRISING THE SAME, AND SILICA | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-12-04 | — | — | WO | disclosed |
| EP-1364224-A1 | MAGNETIC RESONANCE SPECTROSCOPY TO IDENTIFY AND CLASSIFY MICROORGANISMS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2003-11-26 | — | — | EP | disclosed |
| EP-1334769-A1 | Process and catalyst for hydrotreating hydrocarbon oils | Tonen Corporation (JP) | 2003-08-13 | — | — | EP | disclosed |
| US-20030119109-A1 | Efficient 13C/15N double labeling of proteins in a methanol-utilizing strain (Mut+) of pichia pastoris | VAN DEN BURG HARROLD ALFRED (NL) | 2003-06-26 | — | — | US | disclosed |
| US-20030114433-A1 | Targeted bisplatinum polyamines as pro-drugs: selective release of platinum | VIRGINIA COMMONWEALTH UNIVERSITY | 2003-06-19 | — | — | US | disclosed |
| US-20030114706-A1 | Method for preparing formylphosphonic acid | FRANCZYK THADDEUS S (US) | 2003-06-19 | — | — | US | disclosed |
| US-20030099574-A1 | Fluorescence based oxygen sensor systems | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-29 | — | — | US | disclosed |
| US-20030097059-A1 | Magnetic resonance spectroscopy to identify and classify microorganisms | SORRELL TANIA C (AU) | 2003-05-22 | — | — | US | disclosed |
| US-20030078203-A1 | Covalently reactive transition state analogs and methods of use thereof | PAUL, SUDHIR, DR. | 2003-04-24 | — | — | US | disclosed |
| EP-1300391-A1 | PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES | KANEKA CORPORATION (JP) | 2003-04-09 | — | — | EP | disclosed |
| EP-1290017-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF A MOLECULE INTO A CELL | The J. David Gladstone Institutes (US) | 2003-03-12 | — | — | EP | disclosed |
| WO-2003019179-A1 | FLUORESCENCE BASED OXYGEN SENSOR SYSTEMS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-03-06 | — | — | WO | disclosed |
| WO-2003018594-A1 | TARGETED BISPLATINUM POLYAMINES AS PRO-DRUGS: SELECTIVE RELEASE OF PLATINUM | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2003-03-06 | — | — | WO | disclosed |
| WO-2002079223-A9 | COVALENTLY REACTIVE TRANSITION STATE ANALOGS AND METHODS OF USE THEREOF | UNIV TEXAS (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002079223-A2 | COVALENTLY REACTIVE TRANSITION STATE ANALOGS AND METHODS OF USE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-10-10 | — | — | WO | disclosed |
| EP-1236733-A1 | A process for the preparation of disodium pamidronate | Bioindustria Laboratorio Italiano Medicinali S.p.a. (IT) | 2002-09-04 | — | — | EP | disclosed |
| WO-2002067005-A1 | MAGNETIC RESONANCE SPECTROSCOPY TO IDENTIFY AND CLASSIFY MICROORGANISMS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-08-29 | — | — | WO | disclosed |
| EP-0947505-B1 | Process for preparing optically active 4-hydroxy-2-pyrrolidone | TAKASAGO PERFUMERY CO LTD (JP) | 2002-07-17 | — | — | EP | disclosed |
| EP-1214352-A2 | ENHANCED PHAGE DISPLAY LIBRARIES OF HUMAN VH FRAGMENTS AND METHODS FOR PRODUCING SAME | Viventia Biotech Inc. (CA) | 2002-06-19 | — | — | EP | disclosed |
| US-20020052515-A1 | Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof | TAKASAGO INTERNATIONAL CORPORATION | 2002-05-02 | — | — | US | disclosed |
| US-6365755-B1 | REACTING 3,5,6-TRIHYDROXYHEXANOIC ACID WITH AN AMINE THEN PURIFYING THE RESULTING AMMONIUM COMPOUND BY CRYSTALLIZATION; CHEMICAL INTERMEDIATES FOR HMG-COA REDUCTASE INHIBITOR; STABILITY; PREFERENTIAL STEREOCONFIGURATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-04-02 | — | — | US | disclosed |
| EP-1184380-A1 | Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof | Takasago International Corporation (JP) | 2002-03-06 | — | — | EP | disclosed |
| WO-2002016314-A1 | SUBSTITUTED POLYAMINE COMPOUNDS | H. LUNDBECK A/S (DK) | 2002-02-28 | — | — | WO | disclosed |
| US-20020022027-A1 | Compositions and methods for delivery of a molecule into a cell | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-02-21 | — | — | US | disclosed |
| EP-0825189-B1 | 1,4-BENZODIOXIN DERIVATIVES | NISSHIN PHARMA INC (JP) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001090159-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF A MOLECULE INTO A CELL | THE J. DAVID GLADSTONE INSTITUTES (US) | 2001-11-29 | — | — | WO | disclosed |
| US-6320072-B1 | SALTING OUT N-PROTECTED-S-PHENYLCYSTEINE IN FORM OF BASE SALT IN PRESENCE OF WATER | KANEKA CORPORATION (JP) | 2001-11-20 | — | — | US | disclosed |
| US-6306289-B1 | HAVING BOTH DESULFURIZATION ACTIVITY AND A DENITROGENATION ACTIVITY | TONEN CORPORATION (JP) | 2001-10-23 | — | — | US | disclosed |
| US-20010031889-A1 | Method for preparing formylphosphonic acid | FRANCZYK THADDEUS S (US) | 2001-10-18 | — | — | US | disclosed |
| US-6274557-B1 | DIPEPTIDE CONTAINING NITROARGININE OR ESTER OR AMIDE DERIVATIVE | NORTHWESTERN UNIVERSITY | 2001-08-14 | — | — | US | disclosed |
| US-6218570-B1 | CONTACTING AMINOMETHYLPHOSPHONIC ACID WITH WATER, ALCOHOL OR PHENOL; CATALYTIC OXIDATION WITH GAS; FORMYLATION | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2001018058-A2 | ENHANCED PHAGE DISPLAY LIBRARY OF HUMAN VH FRAGMENTS AND METHODS FOR PRODUCING SAME | VIVENTIA BIOTECH INC. (CA) | 2001-03-15 | — | — | WO | disclosed |
| EP-1083222-A2 | Endo-xyloglucan transferase | TAKARA SHUZO CO. LTD. (JP) | 2001-03-14 | — | — | EP | disclosed |
| EP-1067119-A1 | METHOD FOR ISOLATION OF N-PROTECTED S-PHENYLCYSTEINE | KANEKA CORPORATION (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-6130243-A | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES, HYPERGLYCEMIA AND OBESITY IN MAMMALS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 2000-10-10 | — | — | US | disclosed |
| WO-2000058498-A1 | SOLUBLE RECOMBINANT ENDOSTATIN | MERCK & CO., INC. (US) | 2000-10-05 | — | — | WO | disclosed |
| US-6120998-A | INHIBITING EXPRESSION OF ENZYME IN PLANTS BY INTRODUCING A HETEROLOGOUS EXPRESSION VECTOR WHICH PRODUCES ANTISENSE RNA; FOR REGULATING PLANT MORPHOLOGY | TAKARA SHUZO CO., LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
| WO-2000021552-A9 | GLYCOPROTEIN ANTIGENS, ANTIBODIES SPECIFIC THERETO AND METHOD FOR PRODUCING SAME | UNIV TECHNOLOGY CORP (US) | 2000-08-31 | — | — | WO | disclosed |
| CN-1255137-A | Method for preparing formylphosphonic acid | MONSANTO CO (US) | 2000-05-31 | — | — | CN | disclosed |
| US-6054608-A | REACTING AMINOMETHYLPHOSPHONATE WITH WATER OR ALCOHOL OR PHENOL DERIVATIVE IN PRESENCE OF CATALYST AND OXIDIZING GAS TO FORM FORMYLPHOSPHONIC ACID | MONSANTO COMPANY (US) | 2000-04-25 | — | — | US | disclosed |
| WO-2000021552-A1 | GLYCOPROTEIN ANTIGENS, ANTIBODIES SPECIFIC THERETO AND METHOD FOR PRODUCING SAME | UNIVERSITY TECHNOLOGY CORPORATION (US) | 2000-04-20 | — | — | WO | disclosed |
| EP-0992285-A1 | CATALYST FOR HYDROGENATION TREATMENT AND METHOD FOR HYDROGENATION TREATMENT OF HYDROCARBON OIL | TONEN CORPORATION (JP) | 2000-04-12 | — | — | EP | disclosed |
| EP-0986566-A1 | METHOD FOR PREPARING FORMYLPHOSPHONIC ACID | MONSANTO COMPANY (US) | 2000-03-22 | — | — | EP | disclosed |
| US-6001657-A | DETECTING AND ISOLATING CONFORMATIONALLY MODIFIED NUCLEIC ACID; PROVIDING A MONOCLONAL ANTIBODY THAT BINDS MODIFIED NUCLEIC ACID, CONTACTING NUCLEIC ACID TO ANTIBODY COMPLEX | NORTH CAROLINA STATE UNIVERSITY (US) | 1999-12-14 | — | — | US | disclosed |
| EP-0947505-A2 | Process for preparing optically active 4-hydroxy-2-pyrrolidone | Takasago International Corporation (JP) | 1999-10-06 | — | — | EP | disclosed |
| EP-0748310-B1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 1999-06-02 | — | — | EP | disclosed |
| EP-0664786-B1 | ARGININE KETO-AMIDE ENZYME INHIBITORS | CORVAS INT INC (US) | 1999-03-24 | — | — | EP | disclosed |
| EP-0697705-B1 | Solid electrolyte capacitor using polyaniline doped with disulfonic acid | NEC CORP (JP) | 1999-02-17 | — | — | EP | disclosed |
| US-5869454-A | ANTICOAGULANTS | CORVAS INTERNATIONAL, INC. (US) | 1999-02-09 | — | — | US | disclosed |
| WO-1999001479-A1 | CHITOSAN DERIVATIVES AND METHODS OF MANUFACTURING THE SAME | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1999-01-14 | — | — | WO | disclosed |
| US-5840550-A | SPLITS D-GLUCOSYL LINKAGE IN XYLOGLUCAN MOLECULE, LINKS THIS REDUCING END TO NON-REDUCING END OF D-GLUCOSE OF OTHER XYLOGLUCAN MOLECULE; CONTROL OF PLANT MORPHOLOGY E.G. CROSSLINKING OF CELLULOSE IN PLANT CELL WALL | TAKARA SHUZO CO., LTD. (JP) | 1998-11-24 | — | — | US | disclosed |
| WO-1998050391-A1 | METHOD FOR PREPARING FORMYLPHOSPHONIC ACID | MONSANTO COMPANY (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998048826-A1 | INHIBITION OF NITRIC OXIDE SYNTHASE BY AMINO ACIDS AND DIPEPTIDES | NORTHWESTERN UNIVERSITY (US) | 1998-11-05 | — | — | WO | disclosed |
| US-5827881-A | ADMINISTERING FOR TREATMENT OF VIRAL DISEASES OR AS ANTIINFLAMMATORY AGENTS | ITALFARMACO S.P.A. (IT) | 1998-10-27 | — | — | US | disclosed |
| US-5786186-A | DNA encoding enzymes of the glycolytic pathway for use in alcohol producing yeast | WHITBREAD PLC (GB) | 1998-07-28 | — | — | US | disclosed |
| WO-1998016537-A1 | NOVEL COMPOUNDS | ASTRA AKTIEBOLAG (PUBL) (SE) | 1998-04-23 | — | — | WO | disclosed |
| EP-0825189-A1 | 1,4-BENZODIOXIN DERIVATIVES | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1998-02-25 | — | — | EP | disclosed |
| US-5719303-A | USEFUL FOR MEDICALLY TREATING HYPERLIPEMIA | EISAI CO., LTD. (JP) | 1998-02-17 | — | — | US | disclosed |
| US-5597804-A | ANTITHROMBOTIC AGENTS | CORVAS INTERNATIONAL, INC. (US) | 1997-01-28 | — | — | US | disclosed |
| EP-0748310-A1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO S.p.A. (IT) | 1996-12-18 | — | — | EP | disclosed |
| US-5586001-A | ENHANCED HIGH TEMPERATURE ENDURANCE, HUMIDITY RESISTANCE | NEC CORPORATION (JP) | 1996-12-17 | — | — | US | disclosed |
| EP-0742012-A2 | Pharmaceutical composition containing substance inhibiting HSP47 production | Kureha Chemical Industry Co., Ltd. (JP) | 1996-11-13 | — | — | EP | disclosed |
| US-5516694-A | Endo-xyloglucan transferase | TAKARA SHUZO CO., LTD. (JP) | 1996-05-14 | — | — | US | disclosed |
| US-5500342-A | ENZYMATIC OR CHEMICAL DIGESTION | TAKARA SHUZO CO., LTD. (JP) | 1996-03-19 | — | — | US | disclosed |
| EP-0697705-A1 | Solid electrolyte capacitor using polyaniline doped with disulfonic acid | NEC CORPORATION (JP) | 1996-02-21 | — | — | EP | disclosed |
| US-5492903-A | BACTERICIDE | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 1996-02-20 | — | — | US | disclosed |
| EP-0688325-A1 | PHOSPHONIC ACID DERIVATIVES | Eisai Co., Ltd. (JP) | 1995-12-27 | — | — | EP | disclosed |
| US-5449707-A | Graft polymer; inks, paints; storage stability | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1995-09-12 | — | — | US | disclosed |
| WO-1995023128-A1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO S.P.A. (IT) | 1995-08-31 | — | — | WO | disclosed |
| EP-0380038-B1 | 3-phenyl-5,6-dihydrobenz (C) - acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents | DU PONT MERCK PHARMA (US) | 1995-06-28 | — | — | EP | disclosed |
| EP-0640835-A2 | Method for determining sugar chain structure | TAKARA SHUZO CO. LTD. (JP) | 1995-03-01 | — | — | EP | disclosed |
| US-5359058-A | A cephalosporin compound substituted in the 7-position with a (cyclo)alkylideneammonio group | GIST-BROCADES, N.V. (NL) | 1994-10-25 | — | — | US | disclosed |
| EP-0299513-B1 | Azetidine derivatives, compositions and their use | FIDIA GEORGETOWN INST (US) | 1994-10-05 | — | — | EP | disclosed |
| WO-1994020508-A1 | PHOSPHONIC ACID DERIVATIVES | EISAI CO., LTD. (JP) | 1994-09-15 | — | — | WO | disclosed |
| EP-0380943-B1 | New heparinic derivatives and process for their preparation | ALFA WASSERMANN SPA (IT) | 1994-09-07 | — | — | EP | disclosed |
| EP-0382268-B1 | New amino carboxylic acid derivatives | GIST BROCADES NV (NL) | 1994-08-24 | — | — | EP | disclosed |
| EP-0347588-B1 | Heparin derivatives and process for their preparation | ALFA WASSERMANN SPA (IT) | 1994-07-27 | — | — | EP | disclosed |
| US-5318031-A | Method and apparatus for determining chemical states of living animal or human tissue using nuclear magnetic resonance | BRUKER ANALYTISCHE MESSTECHNIK GMBH (DE) | 1994-06-07 | — | — | US | disclosed |
| EP-0312127-B1 | Glycosylated insulin derivatives | UNIV UTAH (US) | 1994-05-04 | — | — | EP | disclosed |
| US-5292903-A | Coupling furfurylamine w/carbonyl compound | THE UNITED STATES DEPARTMENT OF AGRICULTURE AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1994-03-08 | — | — | US | disclosed |
| US-5284558-A | Treating a labelled and charged oligosaccharide with an exoglycosidase to remove the non-reducing monosaccharide; correlating the enzyme specificity with electrophoretic data | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1994-02-08 | — | — | US | disclosed |
| EP-0378357-B1 | Anti-inflammatory 1-heteroaryloxindole-3-carboxamides | PFIZER (US) | 1994-01-12 | — | — | EP | disclosed |
| EP-0378358-B1 | Anti-inflammmatory 1-heteroaryl-3-acyl-2-oxindoles | PFIZER (US) | 1993-11-03 | — | — | EP | disclosed |
| EP-0562836-A1 | Endo-xyloglucan transferase | TAKARA SHUZO CO. LTD. (JP) | 1993-09-29 | — | — | EP | disclosed |
| WO-1993017711-A1 | NEW CYCLODEXTRINS AND NEW FORMULATED DRUGS | AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) | 1993-09-16 | — | — | WO | disclosed |
| EP-0304961-B1 | NOVEL DIPHOSPHONATES AND USE THEREOF IN PHARMACEUTICAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1993-08-11 | — | — | EP | disclosed |
| EP-0246603-B1 | 4-HALOGENO-2-OXYIMINO-3-OXOBUTYRIC ACIDS | Takeda Chemical Industries, Ltd. (JP) | 1992-12-30 | — | — | EP | disclosed |
| EP-0234549-B1 | METHOD FOR PRODUCTION OF CEPHALOSPORIN COMPOUNDS | Takeda Chemical Industries, Ltd. (JP) | 1992-12-16 | — | — | EP | disclosed |
| EP-0499274-A1 | Crystalline penem, its production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-19 | — | — | EP | disclosed |
| EP-0304962-B1 | NOVEL DIPHOSPHONATES AND USE THEREOF IN PHARMACEUTICAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1992-08-19 | — | — | EP | disclosed |
| US-5116854-A | Enzyme inhibitors | PFIZER INC. (US) | 1992-05-26 | — | — | US | disclosed |
| US-5104863-A | Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism | THE PROCTER & GAMBLE COMPANY (US) | 1992-04-14 | — | — | US | disclosed |
| US-5104860-A | Purified or low molecular weight heaprin having a specific carbon-nuclear magnetic resonance | ALFA WASSERMANN S.P.A. (IT) | 1992-04-14 | — | — | US | disclosed |
| EP-0181136-B1 | OXINDOLE ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1992002816-A1 | ELECTROPHORESIS-BASED SEQUENCING OF OLIGOSACCHARIDES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1992-02-20 | — | — | WO | disclosed |
| US-5010063-A | Antithrombotic agent, anticoagulant, reduces hemorrhage | ALFA WASSERMAN S.P.A. (IT) | 1991-04-23 | — | — | US | disclosed |
| WO-1991004988-A1 | POLYGLUCURONIC ACID, PROCESS FOR PREPARING POLYGLUCURONIC ACID AND USE OF POLYGLUCURONIC ACID | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1991-04-18 | — | — | WO | disclosed |
| US-5002954-A | Leukemia, melanoma | DUPONT PHARMACEUTICALS COMPANY | 1991-03-26 | — | — | US | disclosed |
| US-4990504-A | Modulate excitatory amino acid receptor system | FIDIA-GEORGETOWN INSTITUTE FOR THE NEUROSCIENCES (US) | 1991-02-05 | — | — | US | disclosed |
| US-4980464-A | Method for production of cephalosporin compounds | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-12-25 | — | — | US | disclosed |
| US-4968800-A | Novel platinum complex, antineoplastic agent containing the same, and intermediate therefor | KANEBO LIMITED (JP) | 1990-11-06 | — | — | US | disclosed |
| EP-0132349-B1 | ANTIBIOTIC CALLED \"CHLOROPOLYSPORIN\", A PROCESS FOR ITS PREPARATION, AND ITS THERAPEUTIC AND VETERINARY USE | SANKYO COMPANY LIMITED (JP) | 1990-10-10 | — | — | EP | disclosed |
| EP-0382268-A1 | New amino carboxylic acid derivatives | GIST-BROCADES N.V. (NL) | 1990-08-16 | — | — | EP | disclosed |
| EP-0380943-A1 | New heparinic derivatives and process for their preparation | ALFA WASSERMANN S.p.A. (IT) | 1990-08-08 | — | — | EP | disclosed |
| US-4946839-A | ALZHEIMER'S DISEASE | FIDIA-GEORGETOWN INSTITUTE FOR THE NEUROSCIENCES (US) | 1990-08-07 | — | — | US | disclosed |
| US-4946779-A | HYPERGLYCEMIC AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-08-07 | — | — | US | disclosed |
| EP-0380038-A2 | 3-phenyl-5,6-dihydrobenz (C) - acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1990-08-01 | — | — | EP | disclosed |
| WO-1990008145-A1 | ANTI-INFLAMMATORY 1-HETEROARYL-3-ACYL-2-OXINDOLES | PFIZER INC. (US) | 1990-07-26 | — | — | WO | disclosed |
| WO-1990008146-A1 | ANTI-INFLAMMATORY 1-HETEROARYL-OXINDOLE-3-CARBOXAMIDES | PFIZER INC. (US) | 1990-07-26 | — | — | WO | disclosed |
| EP-0378358-A1 | Anti-inflammmatory 1-heteroaryl-3-acyl-2-oxindoles | PFIZER INC. (US) | 1990-07-18 | — | — | EP | disclosed |
| EP-0378357-A1 | Anti-inflammatory 1-heteroaryloxindole-3-carboxamides | PFIZER INC. (US) | 1990-07-18 | — | — | EP | disclosed |
| US-4939256-A | Novel platinum complex, antineoplastic agent containing the same, and intermediate therefor | KANEBO LTD. (JP) | 1990-07-03 | — | — | US | disclosed |
| US-4939131-A | Certain cycloalkane-1,1-diphosphonic acids and derivatives thereof having the ability to treat diseases associated with abnormal calcium and phosphate metabolism | THE PROCTER & GAMBLE COMPANY (US) | 1990-07-03 | — | — | US | disclosed |
| US-4939128-A | Antiischemic agents; circulatory disorders | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-07-03 | — | — | US | disclosed |
| US-4937367-A | Process for the preparation of intermediates for the synthesis of fosfomycin | ZAMBON GROUP S.P.A. (IT) | 1990-06-26 | — | — | US | disclosed |
| US-4923975-A | Valiolamine derivatives and production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-05-08 | — | — | US | disclosed |
| US-4918171-A | ANTIINFLAMMATORY AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-17 | — | — | US | disclosed |
| US-4918077-A | ANTITUMOR AGENTS | E. I. DU PONT DE NEMOURS & CO., INC. (US) | 1990-04-17 | — | — | US | disclosed |
| US-4898878-A | Antioxidant thiohistidine compounds | THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1990-02-06 | — | — | US | disclosed |
| EP-0350051-A1 | Thaz derivatives for enhancemet of cerebral function | Bristol-Myers Squibb Company (US) | 1990-01-10 | — | — | EP | disclosed |
| EP-0173520-B1 | TRICYCLIC OXINDOLE ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1990-01-03 | — | — | EP | disclosed |
| EP-0347588-A1 | Heparin derivatives and process for their preparation | ALFA WASSERMANN S.p.A. (IT) | 1989-12-27 | — | — | EP | disclosed |
| EP-0345073-A1 | Poly (3-(Substituted)-3(Hydroxymethyl) oxetane) and method of preparing same | ARIZONA BOARD OF REGENTS (US) | 1989-12-06 | — | — | EP | disclosed |
| CN-1037341-A | Xitix-2-phosphoric acid ester | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1989-11-22 | — | — | CN | disclosed |
| EP-0339486-A2 | Ester of ascorbic acid 2-phosphate | Takeda Chemical Industries, Ltd. (JP) | 1989-11-02 | — | — | EP | disclosed |
| EP-0114486-B1 | ALKYLATION OF OLEANDOMYCIN | PFIZER INC. (US) | 1989-10-18 | — | — | EP | disclosed |
| US-4859666-A | THAZ derivatives for enhancement of cerebral function | BRISTOL-MYERS COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0125299-B1 | GLYCOSYLATED INSULIN DERIVATIVES | THE UNIVERSITY OF UTAH (US) | 1989-07-19 | — | — | EP | disclosed |
| US-4849438-A | choline saccharinate; phytoprotective agent; use protecting rice from bacterial leaf blight | AGRO-KANESHO CO., LTD. (JP) | 1989-07-18 | — | — | US | disclosed |
| US-4845257-A | 4-halogeno-2-oxyimino-3-oxobutyric acids and derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| US-4837312-A | Chelator-functionalized nucleosides and nucleotides and methods for making same | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1989-06-06 | — | — | US | disclosed |
| US-4833183-A | FILMS, FIBERS, MOLDING MATERIALS EXPLOSIVES | ARIZONA BOARD OF REGENTS (US) | 1989-05-23 | — | — | US | disclosed |
| US-4831053-A | Composition for prophylaxis and therapy of hepatitis | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-05-16 | — | — | US | disclosed |
| US-4827036-A | GLUCOSIDASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-05-02 | — | — | US | disclosed |
| EP-0312127-A2 | Glycosylated insulin derivatives | UNIVERSITY OF UTAH (US) | 1989-04-19 | — | — | EP | disclosed |
| US-4820865-A | INHIBITORS OF BIOSYNTHESIS OF CHOLESTEROL | SANKYO COMPANY, LIMITED (JP) | 1989-04-11 | — | — | US | disclosed |
| EP-0304962-A2 | Novel diphosphonates and use thereof in pharmaceutical compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-03-01 | — | — | EP | disclosed |
| EP-0304961-A2 | Novel diphosphonates and use thereof in pharmaceutical compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-03-01 | — | — | EP | disclosed |
| EP-0300474-A2 | Seikosaponin derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1989-01-25 | — | — | EP | disclosed |
| EP-0299484-A1 | Process for the preparation of intermediates for the synthesis of fosfomycin | ZAMBON GROUP S.p.A. (IT) | 1989-01-18 | — | — | EP | disclosed |
| EP-0299513-A1 | Azetidine derivatives, compositions and their use | FIDIA-GEORGETOWN INSTITUTE FOR THE NEUROSCIENCES (US) | 1989-01-18 | — | — | EP | disclosed |
| US-4762920-A | BETA-LACTAMASE INHIBITOR, SYNERGISTIC WITH PENICILLIN ANTIBIOTICS AND BACTERICIDES | PFIZER, INC. (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0156524-B1 | 2'-CHLOROPENTOSTATIN, A PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUND AND A NOVEL MICROORGANISM FOR PRODUCING THE COMPOUND | WARNER-LAMBERT COMPANY (US) | 1988-05-11 | — | — | EP | disclosed |
| US-4736051-A | REACTING MONOALKALI SALT OF ORGANOPHOSPHORIC MONOESTER WITH EPOXY COMPOUND | KAO CORPORATION (JP) | 1988-04-05 | — | — | US | disclosed |
| US-4730027-A | Method of making styrene-type polymer comprising suspension polymerization conducted in aqueous medium containing combination of polyvinyl alcohol and sulfonated polystyrene or sulfonated styrene-maleic anhydride copolymer | HUNTSMAN CHEMICAL CORPORATION (US) | 1988-03-08 | — | — | US | disclosed |
| US-4723016-A | Preparation of anhydrous organic acid salts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-02-02 | — | — | US | disclosed |
| EP-0251324-A2 | Process for the preparation of antibiotics | ZAMBON S.p.A. (IT) | 1988-01-07 | — | — | EP | disclosed |
| US-4714761-A | OXIDATION, DEHALOGENATION | PFIZER INC. (US) | 1987-12-22 | — | — | US | disclosed |
| EP-0246603-A2 | 4-Halogeno-2-Oxyimino-3-Oxobutyric acids | Takeda Chemical Industries, Ltd. (JP) | 1987-11-25 | — | — | EP | disclosed |
| EP-0097202-B1 | HYDRAZINOPYRIDAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENT | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1987-11-19 | — | — | EP | disclosed |
| US-4695571-A | Tricyclic oxindole antiinflammatory agents | PFIZER INC. (US) | 1987-09-22 | — | — | US | disclosed |
| US-4692518-A | CEFTAZIDIME INTERMEDIATE | ELI LILLY AND COMPANY (US) | 1987-09-08 | — | — | US | disclosed |
| US-4687768-A | OSTEOPOROSIS, ARTHRITIS | THE PROCTER & GAMBLE COMPANY (US) | 1987-08-18 | — | — | US | disclosed |
| US-4686224-A | Oxindole antiinflammatory agents | PFIZER INC. (US) | 1987-08-11 | — | — | US | disclosed |
| EP-0135683-B1 | METHOD FOR PRODUCTION OF CEPHALOSPORIN COMPOUNDS | Takeda Chemical Industries, Ltd. (JP) | 1987-07-22 | — | — | EP | disclosed |
| EP-0074611-B1 | METHOD FOR PRODUCTION OF CEPHALOSPORIN COMPOUNDS | Takeda Chemical Industries, Ltd. (JP) | 1987-07-22 | — | — | EP | disclosed |
| US-4680416-A | Antibiotic CL-1565 complex derivatives | WARNER-LAMBERT COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0087021-B1 | CL 1565 ANTIBIOTIC COMPOUNDS AND THEIR PRODUCTION | WARNER-LAMBERT COMPANY (US) | 1987-06-10 | — | — | EP | disclosed |
| US-4656263-A | 6-β-substituted penicillanic acid compound free of the 6-α-epimer | PFIZER INC. (US) | 1987-04-07 | — | — | US | disclosed |
| US-4644005-A | ANTIARTHRITIC AGENTS | PFIZER INC. (US) | 1987-02-17 | — | — | US | disclosed |
| US-4642365-A | REACTING A PYROCATECHOL DERIVATIVE AND DIHALOPHOSPHOROUS COMPOUND | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-02-10 | — | — | US | disclosed |
| US-4636567-A | CNS DISORDERS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1987-01-13 | — | — | US | disclosed |
| US-4632922-A | Oxomorpholinyl dimer and rescue of anthracycline and mitomycin C damage | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1986-12-30 | — | — | US | disclosed |
| EP-0199591-A2 | Valiolamine derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1986-10-29 | — | — | EP | disclosed |
| US-4610821-A | CENTRAL NERVOUS SYSTEM, THYROTROPIN RELEASING HORMONE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1986-09-09 | — | — | US | disclosed |
| EP-0189662-A1 | Novel diphosphonates and use thereof in pharmaceutical compositions | THE PROCTER & GAMBLE COMPANY (US) | 1986-08-06 | — | — | EP | disclosed |
| EP-0081324-B1 | SUBSTITUTED PHARMACOLOGICALLY ACITVE IMIDAZOLE DERIVATIVES AND THEIR PREPARATION AND USE | Farmos Group Ltd. (FI) | 1986-08-06 | — | — | EP | disclosed |
| US-4599333-A | HYPOTENSIVE AGENTS | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1986-07-08 | — | — | US | disclosed |
| US-4591459-A | Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides | PFIZER INC. (US) | 1986-05-27 | — | — | US | disclosed |
| EP-0061284-B1 | IMPROVED PROCESS FOR THE PREPARATION OF PENICILLANIC ACID ESTERS | PFIZER INC. (US) | 1986-04-23 | — | — | EP | disclosed |
| EP-0175180-A1 | Histargin-related compounds, a process for their preparation and their use as medicaments | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1986-03-26 | — | — | EP | disclosed |
| WO-1986001510-A1 | TRICYCLIC OXINDOLE ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1986-03-13 | — | — | WO | disclosed |
| EP-0173520-A2 | Tricyclic oxindole antiinflammatory agents | PFIZER INC. (US) | 1986-03-05 | — | — | EP | disclosed |
| EP-0095341-B1 | PENICILLANIC ACID DIOXIDE PRODRUG | PFIZER INC. (US) | 1986-02-26 | — | — | EP | disclosed |
| EP-0125299-A4 | GLYCOSYLATED INSULIN DERIVATIVES. | UNIV UTAH (US) | 1986-02-13 | — | — | EP | disclosed |
| US-4564609-A | NERVOUS SYSTEM DISORDERS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1986-01-14 | — | — | US | disclosed |
| US-4557933-A | Antibiotic called \"chloropolysporin\", a process for its preparation, and its therapeutic and veterinary use | SANKYO COMPANY LIMITED (JP) | 1985-12-10 | — | — | US | disclosed |
| EP-0156524-A2 | 2'-Chloropentostatin, a pharmaceutical composition comprising the compound and a novel microorganism for producing the compound | WARNER-LAMBERT COMPANY (US) | 1985-10-02 | — | — | EP | disclosed |
| EP-0154444-A1 | 6-(Aminoacyloxymethyl) penicillanic acid 1, 1-dioxides as beta-lactamase inhibitors | PFIZER INC. (US) | 1985-09-11 | — | — | EP | disclosed |
| US-4536572-A | INSULIN COUPLERS;RESISTS AGGREGATION AND DEPRESSES BLOOD SUGAR LEVELS | UNIVERSITY OF UTAH (US) | 1985-08-20 | — | — | US | disclosed |
| US-4521533-A | BACTERICIDES | PFIZER INC. (US) | 1985-06-04 | — | — | US | disclosed |
| US-4518530-A | 6-β-Substituted penicillanic acids as β-lactamase inhibitors | PFIZER INC. (US) | 1985-05-21 | — | — | US | disclosed |
| US-4517126-A | Penicillanic acid derivative | PFIZER INC. (US) | 1985-05-14 | — | — | US | disclosed |
| US-4517373-A | ANTICHOLESTEROL AGENTS | SANKYO COMPANY, LIMITED (JP) | 1985-05-14 | — | — | US | disclosed |
| US-4517198-A | Diuretic imidazole derivatives | FARMOS GROUP LTD. (FI) | 1985-05-14 | — | — | US | disclosed |
| EP-0074222-B1 | MB-530B DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1985-04-10 | — | — | EP | disclosed |
| EP-0135683-A1 | Method for production of cephalosporin compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0054397-B1 | PROCESS FOR PREPARING ESTERS OF PENICILLANIC ACID SULFONE | PFIZER INC. (US) | 1985-03-20 | — | — | EP | disclosed |
| US-4503040-A | 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors | PFIZER INC. (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0076643-B1 | PROCESSES FOR PREPARING PIROXICAM AND INTERMEDIATES LEADING THERETO | PFIZER INC. (US) | 1985-02-20 | — | — | EP | disclosed |
| EP-0051071-B1 | TRYPTOPHANE DERIVATIVE AND PROCESS FOR PREPARING SAME | AJINOMOTO CO., INC. (JP) | 1985-02-20 | — | — | EP | disclosed |
| EP-0132349-A2 | Antibiotic called \"chloropolysporin\", a process for its preparation, and its therapeutic and veterinary use | SANKYO COMPANY LIMITED (JP) | 1985-01-30 | — | — | EP | disclosed |
| US-4495286-A | Antibiotic complex producing bacterial culture | WARNER-LAMBERT COMPANY (US) | 1985-01-22 | — | — | US | disclosed |
| EP-0025602-B1 | ACYLATED CEPHALOSPORIN ANALOGS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | KYOWA HAKKO KOGYO CO., LTD (JP) | 1984-12-19 | — | — | EP | disclosed |
| EP-0128651-A2 | Pyranones and related compounds and methods for their production and use | WARNER-LAMBERT COMPANY (US) | 1984-12-19 | — | — | EP | disclosed |
| US-4489063-A | HYPOGLYCEMIC | UNIVERSITY OF UTAH | 1984-12-18 | — | — | US | disclosed |
| US-4489064-A | HYPOGLYCEMIC | UNIVERSITY OF UTAH | 1984-12-18 | — | — | US | disclosed |
| EP-0125299-A1 | GLYCOSYLATED INSULIN DERIVATIVES. | UNIV UTAH (US) | 1984-11-21 | — | — | EP | disclosed |
| US-4483982-A | REACTING N-METHYLSACCHARIN WITH (N-2-PYRIDYL) HALOACETAMIDES OR ALKYLACETATES | PFIZER INC. (US) | 1984-11-20 | — | — | US | disclosed |
| EP-0123444-A1 | 4-Substituted-2-azetidinone compound, process of producing the compounds, and medicaments containing the compounds | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1984-10-31 | — | — | EP | disclosed |
| US-4478830-A | HYPOGLYCEMIC AGENTS | UNIVERSITY OF UTAH | 1984-10-23 | — | — | US | disclosed |
| US-4478746-A | Glycosylated insulin derivatives | UNIVERSITY OF UTAH | 1984-10-23 | — | — | US | disclosed |
| US-4474698-A | HALOGENATION | PFIZER INC. (US) | 1984-10-02 | — | — | US | disclosed |
| EP-0051371-B1 | IMIDAZOLYLPYRIDINE THERAPEUTIC AGENTS | PFIZER INC. (US) | 1984-08-29 | — | — | EP | disclosed |
| EP-0063456-B1 | PSEUDO-AMINOSUGARS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1984-08-01 | — | — | EP | disclosed |
| EP-0114486-A2 | Alkylation of oleandomycin | PFIZER INC. (US) | 1984-08-01 | — | — | EP | disclosed |
| WO-1984001896-A1 | GLYCOSYLATED INSULIN DERIVATIVES | UNIV UTAH (US) | 1984-05-24 | — | — | WO | disclosed |
| US-4444686-A | Crystalline penicillin ester intermediate | PFIZER INC. (US) | 1984-04-24 | — | — | US | disclosed |
| US-4432970-A | SYNERGISTIC WITH AMINO ACID DERIVATIVE ANTIBIOTICS | PFIZER INC. (US) | 1984-02-21 | — | — | US | disclosed |
| US-4431508-A | Solid state graphite electrode | NUESTRO MEDICAL CORPORATION | 1984-02-14 | — | — | US | disclosed |
| US-4429116-A | Alkylated oleandomycin containing compounds | PFIZER INC. (US) | 1984-01-31 | — | — | US | disclosed |
| US-4428935-A | BETA-LACTAMASE INHIBITORS | PFIZER INC. (US) | 1984-01-31 | — | — | US | disclosed |
| EP-0097202-A1 | Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1984-01-04 | — | — | EP | disclosed |
| US-4420426-A | BACTERICIDES, ENZYME INHIBITORS | PFIZER INC. (US) | 1983-12-13 | — | — | US | disclosed |
| EP-0095341-A1 | Penicillanic acid dioxide prodrug | PFIZER INC. (US) | 1983-11-30 | — | — | EP | disclosed |
| US-4410709-A | Sulfobetaines | AKADEMIE DER WISSENSCHAFTEN DER DDR (DD) | 1983-10-18 | — | — | US | disclosed |
| EP-0087021-A2 | CL 1565 Antibiotic compounds and their production | WARNER-LAMBERT COMPANY (US) | 1983-08-31 | — | — | EP | disclosed |
| US-4397783-A | HYDRODEHALOGENATION WITH AN ORGANOTIN HYDRIDE | PFIZER INC. (US) | 1983-08-09 | — | — | US | disclosed |
| EP-0083977-A1 | 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor | PFIZER INC. (US) | 1983-07-20 | — | — | EP | disclosed |
| US-4389398-A | GENTAMICINS | SCHERING CORPORATION (US) | 1983-06-21 | — | — | US | disclosed |
| EP-0081324-A2 | Substituted pharmacologically acitve imidazole derivatives and their preparation and use | Farmos Group Ltd. (FI) | 1983-06-15 | — | — | EP | disclosed |
| US-4387219-A | 2-Hydroxy gentamicin compounds | STERLING DRUG INC. (US) | 1983-06-07 | — | — | US | disclosed |
| US-4382888-A | ENZYME INHIBITORS, METALLO PROTEINASES | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4381980-A | FROM AN N-SUBSTITUTED ALLYLAMMONIUM COMPOUND BY CATALYTIC SULFONATION WITH SULFUROUS ACID SALT | AKADEMIE DER WISSENSCHAFTEN DER DDR (DD) | 1983-05-03 | — | — | US | disclosed |
| US-4381263-A | Process for the preparation of penicillanic acid esters | PFIZER INC. (US) | 1983-04-26 | — | — | US | disclosed |
| EP-0076643-A1 | Processes for preparing piroxicam and intermediates leading thereto | PFIZER INC. (US) | 1983-04-13 | — | — | EP | disclosed |
| EP-0074611-A2 | Method for production of cephalosporin compounds | Takeda Chemical Industries, Ltd. (JP) | 1983-03-23 | — | — | EP | disclosed |
| EP-0074222-A1 | MB-530B derivatives, their preparation and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1983-03-16 | — | — | EP | disclosed |
| US-4376204-A | 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam | PFIZER INC. (US) | 1983-03-08 | — | — | US | disclosed |
| US-4361513-A | INTERMEDIATES TO BETA-LACTAMASE INHIBITORS | PFIZER INC. (US) | 1982-11-30 | — | — | US | disclosed |
| EP-0008917-B1 | PENAM-3-CARBOXYLIC ACID 1,1-DIOXIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | PFIZER INC. (US) | 1982-11-24 | — | — | EP | disclosed |
| EP-0063456-A1 | Pseudo-aminosugars, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1982-10-27 | — | — | EP | disclosed |
| EP-0061284-A1 | Improved process for the preparation of penicillanic acid esters | PFIZER INC. (US) | 1982-09-29 | — | — | EP | disclosed |
| EP-0054397-A1 | Process for preparing esters of penicillanic acid sulfone | PFIZER INC. (US) | 1982-06-23 | — | — | EP | disclosed |
| EP-0051071-A1 | TRYPTOPHANE DERIVATIVE AND PROCESS FOR PREPARING SAME | AJINOMOTO CO., INC. (JP) | 1982-05-12 | — | — | EP | disclosed |
| EP-0051371-A2 | Imidazolylpyridine therapeutic agents | PFIZER INC. (US) | 1982-05-12 | — | — | EP | disclosed |
| US-4310627-A | ANTIBIOTIC CULTURES | THE UPJOHN COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4306028-A | Biologically pure culture of Nocardiopsis trehalosei sp. nov. | THE UPJOHN COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| US-4306071-A | ANTINEOPLASTIC ACTIVITY AND CANCER CHEMOTHERAPEUTIC ACTIVITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1981-12-15 | — | — | US | disclosed |
| EP-0000338-B1 | ISOXAZOLO(5,4-C)PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | H.Lundbeck & Co., A/S (DK) | 1981-11-25 | — | — | EP | disclosed |
| US-4302464-A | ANTIULCER AGENTS, ANTI-H2-HISTAMINES | PFIZER INC. (US) | 1981-11-24 | — | — | US | disclosed |
| US-4301287-A | FOR TREATMENT OF PSYCHOLOGICAL AND NERVOUS SYSTEM DISORDERS | H. LUNDBECK & CO. A/S (DK) | 1981-11-17 | — | — | US | disclosed |
| US-4288547-A | CULTURING NUTRIENT MEDIUM CONTAINING D-STREPTAMINE WITH MICROMONOSPORA PURPUREA | SANOFI S.A. (FR) | 1981-09-08 | — | — | US | disclosed |
| US-4287181-A | TO ENHANCE THE EFFECTIVENESS OF B-LACTAM ANTIBIOTICS | PFIZER INC. (US) | 1981-09-01 | — | — | US | disclosed |
| US-4282322-A | Process for enzymatic deacylation of antibiotics | MERCK & CO., INC. (US) | 1981-08-04 | — | — | US | disclosed |
| US-4278676-A | NERVOUS SYSTEM DISORDERS, CYCLIZATION, HYDROLYSIS | H. LUNDBECK & CO. A/S (DK) | 1981-07-14 | — | — | US | disclosed |
| US-4276285-A | SYNERGISTIC BACTERICIDES | PFIZER INC. (US) | 1981-06-30 | — | — | US | disclosed |
| US-4276412-A | AMINOGLYCOSIDE ANTIBIOTICS | THE UPJOHN COMPANY (US) | 1981-06-30 | — | — | US | disclosed |
| EP-0028017-A1 | 3-Piperidinone-4-carboxylic acid derivatives | H.Lundbeck & Co., A/S (DK) | 1981-05-06 | — | — | EP | disclosed |
| EP-0027279-A1 | Isoxazolo(5,4-C)pyridines | H.Lundbeck & Co., A/S (DK) | 1981-04-22 | — | — | EP | disclosed |
| US-4260598-A | ADMINISTERING 6-AMINOPENICILLANIC ACID 1,1-DIOXIDE OR ESTERS THEREOF | PFIZER INC. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4259482-A | NON-SPECIFIC DEPRESSION OF CENTRAL NERVOUS SYSTEM | MEAD JOHNSON & COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| EP-0025602-A1 | Acylated cephalosporin analogs, process for their preparation and pharmaceutical compositions comprising them | KYOWA HAKKO KOGYO CO., LTD (JP) | 1981-03-25 | — | — | EP | disclosed |
| EP-0002927-B1 | PENICILLANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PFIZER INC. (US) | 1981-02-25 | — | — | EP | disclosed |
| US-4241050-A | Penam 1,1-dioxides as beta-lactamase inhibitors | PFIZER INC. (US) | 1980-12-23 | — | — | US | disclosed |
| US-4235967-A | THIENAMYCINS | MERCK & CO., INC. (US) | 1980-11-25 | — | — | US | disclosed |
| US-4234579-A | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors | PFIZER INC. (US) | 1980-11-18 | — | — | US | disclosed |
| US-4229466-A | TREATING NEPHRITIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| US-4208204-A | 3-Hydroxy-3-methylglutaric acid monoamide and derivatives thereof | CALBIOCHEM-BEHRING CORP. (US) | 1980-06-17 | — | — | US | disclosed |
| US-4206142-A | REACTING A STYRYLSULFONYLAMIDINE WITH A BASE | MEAD JOHNSON & COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4201769-A | ENZYME INHIBITORS, SYNERGISTIC | SANKYO COMPANY LIMITED (JP) | 1980-05-06 | — | — | US | disclosed |
| EP-0008917-A1 | Penam-3-carboxylic acid 1,1-dioxides, process for their preparation and pharmaceutical compositions | PFIZER INC. (US) | 1980-03-19 | — | — | EP | disclosed |
| US-4181659-A | Bis-penicillanoyloxy-alkanes | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 1980-01-01 | — | — | US | disclosed |
| US-4179511-A | Antibacterial 3-(5-tetrazolyl) penam compounds | PFIZER INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-4168202-A | THIENAMYCINS | MERCK & CO., INC. (US) | 1979-09-18 | — | — | US | disclosed |
| US-4162323-A | BACTERICIDES | MERCK & CO., INC. (US) | 1979-07-24 | — | — | US | disclosed |
| US-4162324-A | THIENAMYCINS, BACTERICIDES | MERCK & CO., INC. (US) | 1979-07-24 | — | — | US | disclosed |
| EP-0002927-A1 | Penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them | PFIZER INC. (US) | 1979-07-11 | — | — | EP | disclosed |
| US-4145530-A | 2'-Deamino-3'-epiamino-3'-deoxy-XK-88-5 and process for the production thereof | ABBOTT LABORATORIES (US) | 1979-03-20 | — | — | US | disclosed |
| US-4143039-A | ANTIBACTERIAL 3-(5-TETRAZOLYL)PENAM COMPOUNDS | PFIZER INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-4141986-A | Antibiotics 890A2 and 890A5 | MERCK & CO., INC. (US) | 1979-02-27 | — | — | US | disclosed |
| EP-0000338-A2 | Isoxazolo(5,4-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them | H.Lundbeck & Co., A/S (DK) | 1979-01-24 | — | — | EP | disclosed |
| US-4130663-A | ANTITHROMBOGENIC, ANTIHYPERTENSIVE | MEAD JOHNSON & COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4129732-A | BACTERICIDE | PFIZER INC. (US) | 1978-12-12 | — | — | US | disclosed |
| US-4121040-A | CEPHALOSPORIN ANTIBIOTICS | PFIZER INC. (US) | 1978-10-17 | — | — | US | disclosed |
| US-4115385-A | PENICILLINS | PFIZER INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4113942-A | ANTIBACTERIAL | PFIZER INC. (US) | 1978-09-12 | — | — | US | disclosed |
| US-4110439-A | GENTAMICINS | SCHERING CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
| US-4109085-A | ANTIBIOTICS, BACTERICIDES | PFIZER INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4109083-A | CEPHALOSPORIN ANTIBIOTICS | PFIZER INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4096183-A | Styrylsulfonylamidines | MEAD JOHNSON & COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4066657-A | ANTIBACTERIAL AGENTS FOR ANIMAL FEED SUPPLEMENTS | PFIZER INC. (US) | 1978-01-03 | — | — | US | disclosed |
| US-4052455-A | ANALGESICS, BLOOD PLATELET AGGREGATION INHIBITORS | MEAD JOHNSON & COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4049796-A | GENTAMYCINS | SCHERING CORPORATION (US) | 1977-09-20 | — | — | US | disclosed |
| US-4045436-A | ANTIBACTERIAL | PFIZER INC. (US) | 1977-08-30 | — | — | US | disclosed |
| US-4045437-A | ANTIBACTERIAL | PFIZER, INC. (US) | 1977-08-30 | — | — | US | disclosed |
| US-4040992-A | USING N-HYDROXYALKYL QUATERNARY AMMONIUM CARBONYLATE SALTS AS CATALYSTS; POLYURETHANES, POLYISOCYANURATES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1977-08-09 | — | — | US | disclosed |
| US-4039533-A | CEPHALOSPORINS | PFIZER INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-4039532-A | BACTERICIDES | PFIZER INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-4036846-A | ANTIBACTERIAL | PFIZER INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-4031077-A | Antibacterial 3-phosphono penams | PFIZER INC. (US) | 1977-06-21 | — | — | US | disclosed |
| US-4017606-A | CYTOSINE ARABINOSIDE AND HYDROGENATED PYRIMIDINE NUCLEOSIDES | THE UPJOHN COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-3988316-A | BY FERMENTATION OF MICROMONOSPORA | SCHERING CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
| US-3966719-A | ANTIBACTERIAL | PFIZER INC. (US) | 1976-06-29 | — | — | US | disclosed |
| US-3957825-A | PROCESS FOR SYNTHESIZING ZEARALANONE AND RELATED COMPOUNDS | COMMERCIAL SOLVENTS CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
| US-3957811-A | Process for 3-(1-[arylmethyl]tetrazol-5-yl)penams | PFIZER INC. (US) | 1976-05-18 | — | — | US | disclosed |
| US-3953416-A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same | FOLKERS KARL | 1976-04-27 | — | — | US | disclosed |
| US-3952021-A | α-(3,4-Dimethoxyphenethylaminomethyl)-3,4 or 3,5-dihydroxybenzylalcohols and salts thereof | TANABE SEIYAKU CO., LTD. (JA) | 1976-04-20 | — | — | US | disclosed |
| US-3950350-A | PENICILLINS, BACTERICIDES | PFIZER INC. (US) | 1976-04-13 | — | — | US | disclosed |
| US-3950350-A | PENICILLINS, BACTERICIDES | PFIZER INC. (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295866-A1 | Synthesis And Use Of Glycoside Pro-Drug Analogs | GCG, CYP3A5, UGT1A6 | APP 1107/4885PTGS1 93/4885PDE4A 900/4885 |
| US-20210137967-A1 | SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS | HPSE, STS, SULT1A1 | APP 4612/4885PTGS1 604/4885PDE4A 3016/4885 |
| US-11903963-B2 | Short-acting heparin-based anticoagulant compounds and methods | HPSE, STS, SULT1A1 | APP 4612/4885PTGS1 604/4885PDE4A 3016/4885 |
| US-20180134979-A1 | LUBRICANT INCLUDING SILICON-CONTAINING IONIC LIQUID | MUC1, CCR1, TAS1R1 | APP 4384/4885PTGS1 2279/4885PDE4A 4836/4885 |
| US-20170071866-A1 | NANOPARTICLES LOADED WITH ACTIVE INGREDIENTS, THEIR PROCESS OF PREPARATION, AND THEIR USES | MPO, EXOSC9, CD63 | APP 903/4885PTGS1 2469/4885PDE4A 1703/4885 |
| US-20260091054-A1 | Gel-Forming Material and Gel Composition | IL6, CD44, FGF2 | APP 3245/4885PTGS1 21/4885PDE4A 3406/4885 |
| US-20050171002-A1 | Conjugation of a polyoxyalkylene to a peptide, protein, dendrimer or cyclodextrin, by reacting an acrylated polyoxyethylene glycol monomethyl ether with a compound containing amine or mercapto groups; Micheal addition; one reaction step, by-product inhibition | PAM, MLEC, MPEG1 | APP 288/4885PTGS1 2214/4885PDE4A 2713/4885 |
| US-20120041057-A1 | SYNTHESIS AND CHARACTERIZATION OF C8 ANALOGS OF c-di-GMP | CGAS, GMPS, AMPD2 | APP 4599/4885PTGS1 1949/4885PDE4A 16/4885 |
| US-20100249175-A1 | Dicationic compounds which selectively recognize G-quadruplex DNA | DDB1, DNA2, SSBP1 | APP 4851/4885PTGS1 4318/4885PDE4A 2858/4885 |
| US-20230346943-A1 | SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES | DCLRE1A, PCNA, HMBS | APP 2887/4885PTGS1 3475/4885PDE4A 4355/4885 |
| US-20120039800-A1 | Platinum Acridine Anti-Cancer Compounds And Methods Thereof | ACR, TP53, BAD | APP 4692/4885PTGS1 1959/4885PDE4A 2838/4885 |
| US-20130164317-A1 | ANTIMICROBIAL AGENT, BACTERIAL STRAIN, BIOSYNTHESIS, AND METHODS OF USE | SPOUT1, UMPS, NOS1 | APP 3461/4885PTGS1 497/4885PDE4A 370/4885 |
| US-20240066048-A1 | SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS | HPSE, STS, SULT1A1 | APP 4612/4885PTGS1 604/4885PDE4A 3016/4885 |
| US-20220127413-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | ALPI, ITPA, ITPR2 | APP 4096/4885PTGS1 2821/4885PDE4A 1964/4885 |
| US-20060194832-A1 | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | CYP2C19, CYP2D6, CYP3A5 | APP 3880/4885PTGS1 1403/4885PDE4A 431/4885 |
| US-20190047963-A1 | IMIDAZOLES AND IMIDAZOLIUM CATIONS WITH EXCEPTIONAL ALKALINE STABILITY | ALPI, ITPA, ITPR2 | APP 4096/4885PTGS1 2821/4885PDE4A 1964/4885 |
| US-20160244534-A1 | CARBOXYMETHYL-GROUP-CONTAINING MODIFIED HYALURONIC ACID AND/OR SALT THEREOF AND/OR PRODUCTION METHOD FOR CARBOXYMETHYL-GROUP-CONTAINING MODIFIED HYALURONIC ACID AND/OR SALT THEREOF | CD44, CA13, MMP13 | APP 4730/4885PTGS1 1883/4885PDE4A 3428/4885 |
| US-20240277855-A1 | POLYOXYETHYLENE DERIVATIVES AND CONJUGATES THEREOF | NGLY1, NPPA, VEGFA | APP 2039/4885PTGS1 1185/4885PDE4A 3810/4885 |
| US-20050004044-A1 | Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en-22-one 16-0-(2-0-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-(2-0-acetyl-alpha-L-arabinopyranoside)] or OSW-1 and its derivatives for cancer therapeutics | OSBP2, OSBP, OSBPL3 | APP 2027/4885PTGS1 2046/4885PDE4A 3112/4885 |
| US-20230132667-A1 | DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF VIRAL RNA STRUCTURES | TARBP1, TARDBP, SNRPE | APP 3211/4885PTGS1 4160/4885PDE4A 3090/4885 |
| US-10125162-B2 | Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates | DDOST, STT3A, STT3B | APP 3806/4885PTGS1 4623/4885PDE4A 3720/4885 |
| US-11242432-B2 | Imidazoles and imidazolium cations with exceptional alkaline stability | ALPI, ITPA, ITPR2 | APP 4096/4885PTGS1 2821/4885PDE4A 1964/4885 |
| US-20040049074-A1 | Process for producing 3-amino-2-hydroxypropionic acid derivatives | AASDHPPT, HPD, HAAO | APP 166/4885PTGS1 551/4885PDE4A 1956/4885 |
| US-20100048473-A1 | Modified Protein Polymers | ADM2, FGB, FABP3 | APP 998/4885PTGS1 2438/4885PDE4A 3883/4885 |
| US-11993627-B2 | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides | HPSE, STS, CSGALNACT1 | APP 3473/4885PTGS1 2141/4885PDE4A 4403/4885 |
| US-12577599-B2 | Synthesis of human milk oligosaccharides by a beta-N-acetylhexosaminidase from Haloferula sp | LCT, B4GALT1, ENGASE | APP 4022/4885PTGS1 3567/4885PDE4A 3729/4885 |
| US-20150203518-A1 | IONIC LIQUID | PHOSPHO1, CSNK1A1L, CSNK1A1 | APP 3756/4885PTGS1 3010/4885PDE4A 4333/4885 |
| US-20130116417-A1 | Methods for the Development of Vaccines Based on Oligosaccharide-Oligonucleotide Conjugates | DDOST, STT3A, STT3B | APP 3884/4885PTGS1 4618/4885PDE4A 3773/4885 |
| US-20070179176-A1 | Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy | SLC10A2, SLC10A1, TPMT | APP 3559/4885PTGS1 756/4885PDE4A 1037/4885 |
| US-20240167070-A1 | METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Ny-HYDROXY- OR Ny-AMINO-L-ASPARAGINE | ANPEP, DNPEP, ASNS | APP 2778/4885PTGS1 2485/4885PDE4A 520/4885 |
| US-20050142649-A1 | Covalently reactive transition state analogs and methods of use thereof | SPR, FCGR3B, CD2 | APP 4272/4885PTGS1 2584/4885PDE4A 2943/4885 |
| US-20110235150-A1 | ELECTROCHROMIC MATERIAL AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | EPN1, RPS3A, RPS10 | APP 3202/4885PTGS1 627/4885PDE4A 4434/4885 |
| US-20020052515-A1 | Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof | ABHD5, ALKBH3, APEH | APP 4475/4885PTGS1 1144/4885PDE4A 2959/4885 |
| US-20260099107-A1 | TONER | SRMS, CHD3, MSR1 | APP 2170/4885PTGS1 4116/4885PDE4A 3028/4885 |
| US-20050256032-A1 | Polyoxyalkylene compound and method for making | PAM, SRM, SMS | APP 2792/4885PTGS1 344/4885PDE4A 3677/4885 |
| US-20110230672-A1 | SINGLE-WALLED METAL OXIDE NANOTUBES | AQP1, AQP3, NEDD4 | APP 3388/4885PTGS1 3272/4885PDE4A 4648/4885 |
| US-20060135784-A1 | PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES | AASDHPPT, HPD, HAAO | APP 166/4885PTGS1 599/4885PDE4A 1932/4885 |
| US-20080145335-A1 | Analogs of Glycyl-Prolyl-Glutamate | GLS, GLUL, HIF1A | APP 239/4885PTGS1 75/4885PDE4A 1935/4885 |
| US-20010031889-A1 | Method for preparing formylphosphonic acid | PHOSPHO1, PNPO, MPHOSPH6 | APP 3514/4885PTGS1 1217/4885PDE4A 3809/4885 |
| US-20120264702-A1 | Synthesis And Use Of Glycoside Derivatives of Propofol | CYP3A5, CYP3A4, UGT1A4 | APP 1893/4885PTGS1 282/4885PDE4A 2045/4885 |
| US-20040180852-A1 | Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus | CD4, FCGRT, OGFR | APP 2898/4885PTGS1 4632/4885PDE4A 4619/4885 |
| US-20150216993-A1 | MULTIFUNCTIONAL SMALL MOLECULES | PAM, CHRM3, GRM6 | APP 3399/4885PTGS1 2492/4885PDE4A 790/4885 |
| US-20150087852-A1 | FUNCTIONALIZED SINGLE-WALLED NANOTUBES AND METHODS THEREOF | SOD1, TLN1, NOXO1 | APP 4357/4885PTGS1 3358/4885PDE4A 4722/4885 |
| US-20110287031-A1 | Covalently reactive transition state analogs and methods of use thereof | SPR, FCGR3B, CD2 | APP 4272/4885PTGS1 2584/4885PDE4A 2943/4885 |
| US-20050119298-A1 | Enantiomer (-) of tenatoprazole and the therapeutic use thereof | CYP2C19, CYP2D6, CYP3A5 | APP 3165/4885PTGS1 1129/4885PDE4A 245/4885 |
| US-20160228581-A1 | MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME | ABCB7, FECH, CYC1 | APP 3455/4885PTGS1 659/4885PDE4A 4700/4885 |
| US-20140299817-A1 | Bimetallic Catalysts for CO2 Hydrogenation and H2 Generation from Formic Acid and/or Salts Thereof | CA1, CA3, CA2 | APP 1506/4885PTGS1 1733/4885PDE4A 4861/4885 |
| US-20140193334-A1 | Targeted Delivery and Prodrug Designs for Platinum-Acridine Anti-Cancer Compounds and Methods Thereof | ERBB3, EGFR, ESR1 | APP 4590/4885PTGS1 4562/4885PDE4A 4050/4885 |
| US-10300469-B1 | Metal-ligand cooperative catalysis through N-H arm deprotonation/pyridine dearomatiztion for efficient hydrogen generation from formic acid | PSPH, PNN, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | APP 1777/4885PTGS1 3468/4885PDE4A 4485/4885 |
| US-20160068504-A1 | CYCLIC ORTHO ESTER FUEL ADDITIVE | AQP1, LIPG, AQP3 | APP 2661/4885PTGS1 3055/4885PDE4A 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.